Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, Primrose Tothanarungroj, Luis Antonio Díaz, Juan Pablo Arab, Pimtawan Jatupornpakdee, Mark D. Muthiah, Kwanjit Duangsonk, Won-Mook Choi, Daniel Q. Huang, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul, Amit G. Singal, Ju Dong Yang
Clin Mol Hepatol 2025;31(3):1058-1070. Published online April 11, 2025
Background/Aims Harmful alcohol use is a substantial contributor to liver diseases, liver cancer, and extrahepatic neoplasms. Patterns of alcohol consumption have shifted over recent decades. This study evaluates trends in alcohol-associated liver disease (ALD) and alcohol-attributable cancers in the United States (US) from 2000 to 2021.
Methods Using the methodological framework of the Global Burden of Disease Study 2021, we analyzed trends in incidence, prevalence, and mortality from ALD and alcohol-attributable cancers in the US.
Results In 2021, there were 28,340 new cases of ALD, 227,730 prevalent cases, and 21,860 deaths attributed to ALD in the US. From 2000 to 2021, ALD incidence, prevalence, and mortality increased by 43%, 36%, and 79%, respectively. The age-standardized incidence and death rate of ALD rose disproportionately among females compared to males. For alcohol-attributable cancers, primary liver cancer, colorectal cancer, and esophageal cancer accounted for the largest share of deaths in 2021. Age-standardized death rates increased significantly for primary liver cancer (annual percent change [APC] 2.21%, 95% confidence interval [CI] 1.70–2.73%) and other pharyngeal cancer (APC 1.35%, 95% CI 1.08–1.62%).
Conclusions The burden of ALD is substantial and continues to rise in the US, with a particularly notable increase among females. Mortality from alcohol-attributable cancers is also increasing, mainly driven by primary liver cancer and pharyngeal cancer. However, system-wise, gastrointestinal cancer had the highest death attributable to alcohol. These findings highlight the urgent need for public health strategies to tackle ALD, primary liver cancer, and alcoholattributable extrahepatic malignancies.
Citations
Citations to this article as recorded by
Rising burden of steatotic liver disease in women of childbearing age and projections to 2035 Youxin Wang, Ruiqiu Chen, Shi Yan Lee, Eunice X.X. Tan, Mark Muthiah, Zhou Yu, Margaret L.P. Teng, Jazleen Leo, Cheng Han Ng, Ashok Choudhury, Daniel Q. Huang JHEP Reports.2026; 8(1): 101646. CrossRef
MetALD: new insights and unraveling therapeutic potential Yue Feng, PanShiLi Han, Tao Liu, YanHang Gao Metabolism and Target Organ Damage.2025;[Epub] CrossRef
Sex Disparity in Major Adverse Liver Outcome and Major Adverse Cardiac Event in Alcohol‐Associated Liver Disease Pojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, Mark D. Muthiah, Suthat Liangpunsakul Liver International.2025;[Epub] CrossRef
Advancing Policy and Practice in Alcohol-Associated Liver Disease and Alcohol-Attributable Cancer: Correspondence to the editorial on “Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications” Pojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, Amit G. Singal, Ju Dong Yang Clinical and Molecular Hepatology.2025;[Epub] CrossRef
Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis Pojsakorn Danpanichkul, Yanfang Pang, Donghee Kim, Thanathip Suenghataiphorn, Donghyun Ko, Andrew F. Ibrahim, Vitchapong Prasitsumrit, Kwanjit Duangsonk, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul Alcohol, Clinical and Experimental Research.2025; 49(11): 2451. CrossRef
Consumo de alcohol y cirrosis en mujeres: un riesgo subestimado P. Huerta, J.P. Arab, L.A. Díaz Revista de Gastroenterología de México.2025; 90(4): 509. CrossRef
Alcohol use and cirrhosis in women: An underestimated risk P. Huerta, J.P. Arab, L.A. Díaz Revista de Gastroenterología de México (English Edition).2025; 90(4): 509. CrossRef
Background/Aims Given the increase in prevalence of metabolic diseases, we investigated their long-term impacts on the outcomes of chronic hepatitis B (CHB) patients receiving nucleos(t)ide analogue (NA) treatment.
Methods We analyzed data from CHB patients for whom initiated NA treatment from 30 centers. We balanced patient characteristics with and without metabolic disease (diabetes, obesity, dyslipidemia, and hypertension) via propensity-score matching (PSM) to evaluate adverse outcomes.
Results The study included 4,500 patients. PSM yielded 909 pairs of patients with balanced characteristics. When stratified by the number of metabolic diseases, only patients with ≥2 metabolic diseases had an increased cumulative incidence of cirrhosis and overall death. However, when stratified by the presence of diabetes (regardless of the presence or number of other metabolic diseases), patients with diabetes (versus those without) had a significantly higher cumulative incidence of all outcomes: cirrhosis (P=0.009), hepatocellular carcinoma (HCC, P=0.023), and overall, liver-related, and non-liver-related death (P<0.001, P=0.026 and P<0.001, respectively). Having ≥2 metabolic diseases was associated with cirrhosis, overall death, and non-liver-related death but not HCC or liver-related death, while diabetes was significantly associated with a higher risk of all outcomes: cirrhosis (hazard ratio [HR]=3.75, P=0.004), HCC (HR=2.02, P=0.020), and overall, liver-related, and non-liver-related death (HR=2.53, P<0.001; HR=2.65, P=0.016; HR=2.38, P<0.001).
Conclusions Having two or more metabolic diseases was associated with a higher risk of cirrhosis, overall death, and non-liver-related death, but having diabetes as a single metabolic disease was significantly associated with all adverse outcomes including cirrhosis, HCC, and overall, liver-related, and non-liver-related death.
Citations
Citations to this article as recorded by
Differential HCC risk among HBV indeterminate types at baseline and by phase transition Rui Huang, Huy N Trinh, Satoshi Yasuda, Angela Chau, Mayumi Maeda, Ai-Thien Do, Daniel Q Huang, Takanori Ito, Takashi Honda, Masatoshi Ishigami, Ritsuzo Kozuka, Carmen Monica Preda, Cheng-Hao Tseng, Sebastián Marciano, Pei-Chien Tsai, Dong Hyun Lee, Chris Gut.2025; 74(11): 1873. CrossRef
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis Jie Li, Liang Xu, Fajuan Rui, Sally Tran, Pei-Chien Tsai, Youwen Tan, Hidenori Toyoda, Qing-Lei Zeng, Huy Trinh, Yao-Chun Hsu, Tsunamasa Watanabe, Hiroshi Abe, Hiroyuki Motoyama, Yoko Yoshimaru, Takanori Suzuki, Taeang Arai, Masanori Atsukawa, Phillip Vut Hepatology.2025;[Epub] CrossRef
Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment Jian Wang, Tao Fan, Zhiyi Zhang, Li Zhu, Shaoqiu Zhang, Ye Xiong, Chun Shan, Chao Jiang, Shengxia Yin, Xin Tong, Renling Yao, Juan Xia, Xiaomin Yan, Yu Shi, Yuxin Chen, Xingxiang Liu, Huali Wang, Haixia Zhang, Chuanwu Zhu, Qun Zhang, Chao Wu, Rui Huang Emerging Microbes & Infections.2025;[Epub] CrossRef
Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Haruki Uojima, Daniel Q. Huang, Takashi Honda, Yasuhito Tanaka, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masaru Enomoto, Masanori Ats eClinicalMedicine.2025; 87: 103407. CrossRef
Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn Journal of Gastroenterology and Hepatology.2025; 40(11): 2750. CrossRef
Correspondence to editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021” Pojsakorn Danpanichkul, Luis Antonio Diaz, Kanokphong Suparan, Karn Wijarnpreecha, Juan Pablo Arab Clinical and Molecular Hepatology.2025; 31(2): e200. CrossRef
Antifibrotic potential of reserpine (alkaloid) targeting Keap1/Nrf2; oxidative stress pathway in CCl4-induced liver fibrosis Aamir Sohail, Faiza Shams, Aleeza Nawaz, Qurrat ul Ain, Bushra Ijaz Chemico-Biological Interactions.2025; 407: 111384. CrossRef
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, Pietro Lampertico, Maria Buti, Claude B. Sirlin, Mindie H. Nguyen, Rohit Loomba Nature Reviews Gastroenterology & Hepatology.2023; 20(12): 797. CrossRef
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males than females. The estimated global prevalence of NAFLD among adults is 32% and is higher among males (40%) compared to females (26%). The global prevalence of NAFLD has increased over time, from 26% in studies from 2005 or earlier to 38% in studies from 2016 or beyond. The prevalence of NAFLD varies substantially by world region, contributed by differing rates of obesity, and genetic and socioeconomic factors. The prevalence of NAFLD exceeds 40% in the Americas and South-East Asia. The prevalence of NAFLD is projected to increase significantly in multiple world regions by 2030 if current trends are left unchecked. In this review, we discuss trends in the global incidence and prevalence of NAFLD and discuss future projections.
Citations
Citations to this article as recorded by
Associations between per- and polyfluoroalkyl substances and metabolic dysfunction-associated steatotic liver disease in adolescents and young adults: modifying roles of age, lifestyle factors, and PNPLA3 genotype Shiwen Li, Jiawen Carmen Chen, Elizabeth Costello, Douglas I. Walker, Jesse A. Goodrich, Lily Dara, Lucy Golden-Mason, Ana C. Maretti-Mira, Scott M. Bartell, Veronica M. Vieira, Tanya L. Alderete, Michael I. Goran, Zhanghua Chen, Frank D. Gilliland, Britt Environmental Research.2026; 288: 123320. CrossRef
Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review Nadian N. Bailey, Stephen J. Peterson, Manish A. Parikh, Kaedrea A. Jackson, William H. Frishman Cardiology in Review.2025; 33(5): 402. CrossRef
LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases Genshan Zhang, Wei Jiang, Fangxun He, Jie Fu, Xiangshang Xu, Xuelai Luo, Zhixin Cao The Journal of Clinical Endocrinology & Metabolism.2025; 110(2): e231. CrossRef
Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024 Abraham Koshy Journal of Clinical and Experimental Hepatology.2025; 15(1): 102406. CrossRef
Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies Ning Ma, Meena B. Bansal, Jaime Chu, Mark Woodward, Andrea D. Branch Journal of Environmental Sciences.2025; 155: 329. CrossRef
Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T Collin J. Buelo, Julia Velikina, Lu Mao, Ruiyang Zhao, Qing Yuan, Mounes Aliyari Ghasabeh, Stefan Ruschke, Dimitrios C. Karampinos, David T. Harris, Ryan J. Mattison, Michael R. Jeng, Ivan Pedrosa, Ihab R. Kamel, Shreyas Vasanawala, Takeshi Yokoo, Scott B Magnetic Resonance in Medicine.2025; 93(1): 330. CrossRef
Detección de enfermedad hepática avanzada incorporando el uso de la elastografía de transición en atención primaria Mar Noguerol Álvarez, Ma Paz Valer López Fando, Carolina Torrijos Bravo, Ma Carmen Gómez Ortiz, Belén Piqueras Alcohol, Antonio Guardiola Arévalo, Gema De la Poza Gómez, Zahara Pascual García, Sandra Rey Rodríguez, Raquel Iglesias Sigüenza, Esther Ledesma Gastroenterología y Hepatología.2025; 48(3): 502242. CrossRef
A bio-guided search of anti-steatotic compounds in Opuntia stricta var. dillenii by fast centrifugal partition chromatography Sayra N. Serrano-Sandoval, Sara Parralejo-Sanz, M. Gloria Lobo, M. Pilar Cano, Marilena Antunes-Ricardo Food Chemistry.2025; 464: 141682. CrossRef
Delphinidin or α‐amyrin attenuated liver steatosis and metabolic disarrangement in rats fed a high‐fat diet Bassam Mohamed Ali, Eman M. Elbaz, Asmaa K. Al‐Mokaddem, Soad Z. El‐Emam, Magdy M. Awny BioFactors.2025;[Epub] CrossRef
Fibroblast growth factor 21: update on genetics and molecular biology Daniel R. Barros, Robert A. Hegele Current Opinion in Lipidology.2025; 36(2): 88. CrossRef
Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar Molecular and Cellular Endocrinology.2025; 595: 112404. CrossRef
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease? Huiyan Duan, Minmin Gong, Gang Yuan, Zhi Wang Journal of Clinical and Experimental Hepatology.2025; 15(2): 102459. CrossRef
Spirulina platensis Peptide-Loaded Nanoliposomes Alleviate Hepatic Lipid Accumulation in Male Wistar Rats by Influencing Redox Homeostasis and Lipid Metabolism via the AMPK Signaling Pathway Katayoon Karimzadeh, Suraj Unniappan, Asgar Zahmatkesh Applied Biochemistry and Biotechnology.2025; 197(3): 1696. CrossRef
Characteristics and survival of patients with viral versus nonviral associated hepatocellular carcinoma: a multicenter cohort study Mohamed El-Kassas, Eman M.F. Barakat, Hend Ibrahim Shousha, Mohamed Kohla, Mohamed Said, Ehab Fawzy Moustafa, Ahmed Tawheed, Mostafa Abd Alfattah Shamkh, Mohamed Mahmoud Nabeel, Eman Elkhateeb, Hossam Dabees, Mohamed Omar Abdelmalek, Hamdy Sayed, Nourhan European Journal of Gastroenterology & Hepatology.2025; 37(1): 83. CrossRef
Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers Jaejun Lee, Dong Yeup Lee, Jae Hyeop Jung, Eunkyoung Bae, Jeong A. Yu, Hyun Yang Journal of Physical Activity and Health.2025; 22(3): 323. CrossRef
FrozONE: quick cell nucleus enrichment for comprehensive proteomics analysis of frozen tissues Lukas A Huschet, Fabian P Kliem, Peter Wienand, Claudia M Wunderlich, Andrea Ribeiro, Isabel Bustos-Martínez, Ángel Barco, F Thomas Wunderlich, Maciej Lech, Maria S Robles Life Science Alliance.2025; 8(3): e202403130. CrossRef
Quantitative Liver Fat Assessment by Handheld Point-of-Care Ultrasound: A Technical Implementation and Pilot Study in Adults Dorathy Tamayo-Murillo, Jake T. Weeks, Cody A. Keller, Michael Andre, Celene Gonzalez, Andrew Li, Eduardo Grunvald, Joy Liau, Sedighe Hosseini Shabanan, Tanya Wolfson, Jingyi Zuo, Adam Robinson, Carolina Amador Carrascal, Nevada Sanchez, Scott B. Reeder, Ultrasound in Medicine & Biology.2025; 51(3): 475. CrossRef
Human umbilical cord derived-mesenchymal stem cells alleviate lipid metabolism disturbances of hepatocytes via mitochondrial transport Jing Xue, Xiangnan Hu, Suying Xia, Pengfei Ren, Aihong Wang Gastroenterology & Endoscopy.2025; 3(1): 47. CrossRef
Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Nonalcoholic Steatohepatitis in Mice Rui Zuo, Mi Wang, Yun-Ting Wang, YangPing ShenTu, Alexandra K. Moura, Ying Zhou, Kiana Roudbari, Jenny Z. Hu, Pin-Lan Li, JiuKuan Hao, Xiang Li, Yang Zhang The American Journal of Pathology.2025; 195(3): 542. CrossRef
Insights of direct and indirect regulation of PXR through phosphorylation in fatty liver disease Veronia Basaly, Anisha Bhattacharya, Grace L. Guo Molecular Pharmacology.2025; 107(2): 100014. CrossRef
The impact of diet-induced obesity on 5 fluorouracil-induced tumor and liver immune cell cytotoxicity Brandon N. VanderVeen, Thomas D. Cardaci, Brooke M. Bullard, Christian A. Unger, Jeffrey C. Freeman, Reilly T. Enos, Michael Shtutman, Michael D. Wyatt, Daping Fan, E. Angela Murphy American Journal of Physiology-Cell Physiology.2025; 328(1): C56. CrossRef
Fermented rhubarb alleviates metabolic dysfunction-associated steatotic liver disease symptoms by modulating gut microbiota and activating the hepatic insulin signaling pathway Heng Yuan, Junyu Zhou, Ting Zhang, Xuangao Wu, Chen Li, Hee-Jong Yang, Do Yeon Jeong, Sunmin Park Food Bioscience.2025; 63: 105720. CrossRef
Exploring the hepatic benefits of skipjack tuna (Katsuwonus pelamis) dark muscle hydrolysate in high-fat diet-induced non-alcoholic fatty liver disease Fangfang Huang, Qingfei Dai, Kewei Zheng, Qingbao Ma, Yu Liu, Wei Jiang, Xiaojun Yan Food Bioscience.2025; 63: 105786. CrossRef
A Pragmatic Management Approach for Metabolic Dysfunction-Associated Steatosis and Steatohepatitis Neha Shah, Arun J. Sanyal American Journal of Gastroenterology.2025; 120(1): 75. CrossRef
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases Mingyu Wu, Ke Li, Jiabin Wu, Xianyi Ding, Xiaotong Ma, Wenhong Wang, Weihua Xiao Pharmacological Research.2025; 212: 107571. CrossRef
The relationship between anthropometric indices and non-alcoholic fatty liver disease in adults: a cross-sectional study Mina Radmehr, Reza Homayounfar, Abolghasem Djazayery Frontiers in Nutrition.2025;[Epub] CrossRef
Monascus pilosus SWM-008 red mold rice and its components, monascinol and monascin, reduce obesity in a high-fat diet-induced rat model through synergistic modulation of gut microbiota and anti-lipogenesis Chin-Feng Liu, Hui-Tzu Chuang, Chia-Shu Wang, Ya-Wen Hsu, Tzu-Ming Pan, Chun-Lin Lee Food & Function.2025; 16(3): 966. CrossRef
Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank Yanan Qiao, Yue Wang, Cheng Chen, Yueqing Huang, Chunhua Zhao Cardiovascular Diabetology.2025;[Epub] CrossRef
A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis Jeayeon Park, Goh Eun Chung, Yoosoo Chang, So Eun Kim, Won Sohn, Seungho Ryu, Yunmi Ko, Youngsu Park, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim Gut and Liver.2025; 19(1): 126. CrossRef
Bioinformatic Analysis for Exploring Target Genes and Molecular Mechanisms of Cadmium‐Induced Nonalcoholic Fatty Liver Disease and Targeted Drug Prediction Le Zhang, Rui Wang, Qian Xue, Yongjie Wang, Jiayunzhu Xu, Chaofan Wang, Xin Fang, Shidi Gao, Haiying Zhang, Li Guo Journal of Applied Toxicology.2025; 45(5): 858. CrossRef
Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study Ximing Wang, Jingxiang Sun, Na Chang, Menghan Liu, Shuai Zhang BMC Medical Imaging.2025;[Epub] CrossRef
Cell–cell communications in the brain of hepatic encephalopathy: The neurovascular unit Kyuwan Choi, Yena Cho, Yerin Chae, So Yeong Cheon Life Sciences.2025; 363: 123413. CrossRef
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020 Xin Qiu, Shuang Shen, Nizhen Jiang, Yifei Feng, Guodong Yang, Donghong Lu BMC Gastroenterology.2025;[Epub] CrossRef
The cross–sectional association between ultra-processed food intake and metabolic dysfunction-associated steatotic liver disease Natalie Sun, Brenton Prescott, Jiantao Ma, Vanessa Xanthakis, Paula A. Quatromoni, Michelle T. Long, Maura E. Walker Clinical Nutrition ESPEN.2025; 66: 215. CrossRef
Risk factor assessment of prediabetes and diabetes based on epidemic characteristics in new urban areas: a retrospective and a machine learning study Li Xu, Xiangcheng Sun, Ning Wang, Yiyi Wang, Yan Li, Chuan Zhang Scientific Reports.2025;[Epub] CrossRef
Preventive role of Pastinaca sativa in mitigating metabolic dysfunction-associated steatotic liver disease via modulation of metabolic endotoxemia Ji-Eun Park, Hye-Bin Lee, Yu Ra Lee, Guijae Yoo, Hee-Kyoung Son, Sang Yoon Choi, Miri Park, Ho-Young Park npj Science of Food.2025;[Epub] CrossRef
Liver diseases: epidemiology, causes, trends and predictions Can Gan, Yuan Yuan, Haiyuan Shen, Jinhang Gao, Xiangxin Kong, Zhaodi Che, Yangkun Guo, Hua Wang, Erdan Dong, Jia Xiao Signal Transduction and Targeted Therapy.2025;[Epub] CrossRef
Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD) Ilaria Barchetta, Michele Zampieri, Flavia Agata Cimini, Sara Dule, Federica Sentinelli, Giulia Passarella, Alessandro Oldani, Katsiaryna Karpach, Maria Giulia Bacalini, Marco Giorgio Baroni, Anna Reale, Maria Gisella Cavallo International Journal of Molecular Sciences.2025; 26(3): 1271. CrossRef
Comparison Between the Impact of Diabetes Mellitus on Liver Diseases and Vice Versa Among Saudi and Egyptian Patients Madiha R. Mahmoud, Somia Ibrahim, Mona M. Shahien, Amal Daher Alshammari, Fahaad S. Alenazi, Fayez Alreshidi, Ahmed Aljadani, Ashraf Abdel Khalik, Abeer H. Elhaj, Amany M. Khalifa, Hend Faleh Alreshidi, Hemat El-Sayed El-Horany, Kamaleldin B. Said, Marwa Healthcare.2025; 13(4): 376. CrossRef
Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management Mariangela Rondanelli, Sara Borromeo, Alessandro Cavioni, Clara Gasparri, Ilaria Gattone, Elisa Genovese, Alessandro Lazzarotti, Leonardo Minonne, Alessia Moroni, Zaira Patelli, Claudia Razza, Claudia Sivieri, Eugenio Marzio Valentini, Gaetan Claude Barri Metabolites.2025; 15(2): 127. CrossRef
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies Maria V. Bourganou, Maria Eleni Chondrogianni, Ioannis Kyrou, Christina-Maria Flessa, Antonios Chatzigeorgiou, Evangelos Oikonomou, Vaia Lambadiari, Harpal S. Randeva, Eva Kassi International Journal of Molecular Sciences.2025; 26(4): 1589. CrossRef
Aurantio‐Obtusin Regulates Gut Microbiota and Serum Metabolism to Alleviate High‐Fat Diet‐Induced Obesity‐Associated Non‐Alcoholic Fatty Liver Disease in Mice Zhaoyong Li, Yao Jin, Huashan Zhao, Yuyan Gu, Yaxin Zhang, Saibo Cheng, Lifang Zhang, Peikun He, Xiaoyu Liu, Yuhua Jia Phytotherapy Research.2025; 39(5): 1946. CrossRef
New insights into the antiadipogenic effect of dihydromyricetin by restoring lipid homeostasis between TG and PE in white adipose tissue Lu Liu, Nanxi Dong, Houxue Cui, Sihong Li, Xiang Ma, Dong Niu Food Bioscience.2025; 66: 106151. CrossRef
Bioengineered extracellular vesicles: The path to precision medicine in liver diseases Ashmit Mittal, Vibhuti R Jakhmola, Sukriti Baweja Liver Research.2025; 9(1): 17. CrossRef
Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease Meenakshi Vachher, Kohinoor Kaur, Manisha Marothia, Archana Burman, Deepanjana, Savita Bansal Human Nutrition & Metabolism.2025; 40: 200305. CrossRef
Non alkolik yağlı karaciğer hastalığı ile kafein alımı arasındaki ilişki İzel Akkaya, İlknur Gökçe Yıldırım Sağlık Profesyonelleri Araştırma Dergisi.2025; 7(1): 47. CrossRef
Borneol Ameliorates Non‐Alcoholic Fatty Liver Disease via Promoting AMPK‐Mediated Lipophagy Shalemraju Sriramdasu, Shivam Sharma, Abid Reza Ansari, Nikhil Vinayak Phatak, Kulbhushan Tikoo Journal of Biochemical and Molecular Toxicology.2025;[Epub] CrossRef
Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Chaula Desai, Sweta Lohani, Anuj R. Sharma, Lucas Schwartz, Saigopal R. Gujjula, Adhithya Baskar, Udhaya Baskar, Suriya Baskar, Anush Vasikaran Journal of Clinical Gastroenterology.2025;[Epub] CrossRef
Screening for advanced liver disease incorporating the use of transitional elastography in primary care Mar Noguerol Álvarez, M. Paz Valer López Fando, Carolina Torrijos Bravo, M. Carmen Gómez Ortiz, Belén Piqueras Alcohol, Antonio Guardiola Arévalo, Gema De la Poza Gómez, Zahara Pascual García, Sandra Rey Rodríguez, Raquel Iglesias Sigüenza, Esther Ledesma Gastroenterología y Hepatología (English Edition).2025; 48(3): 502242. CrossRef
Impact of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease on mortality Jung-Hwan Kim, Yaeji Lee, Chung-Mo Nam, Yu-Jin Kwon, Ji-Won Lee Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(6): 103965. CrossRef
Diosgenin alleviates lipid accumulation in NAFLD through the pathways of ferroptosis defensive and executive system Linya Wang, Hongzhuan Yu, Dongxian Wang, Guoliang Yin, Suwen Chen, Xin Zhang, Wenfei Yu, Decheng Meng, Hongshuai Liu, Wenying Jiang, Fengxia Zhang The Journal of Nutritional Biochemistry.2025; 140: 109886. CrossRef
Efecto del fruto de Euterpe oleracea (asaí) sobre el daño hepático inducido por fructosa y etanol en ratas. Jossue Humberto PAREDES CONTRERAS, Geri MOLLO DAVILA, Ariana Vanessa ROLDAN CUBA, Frank SAMANIEGO TIAHUALLPA, Sharon CÓRDOBA YAMAUCHI, Óscar Gustavo HUAMÁN GUTIERREZ Nutrición Clínica y Dietética Hospitalaria.2025;[Epub] CrossRef
Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study Jong Hee Lee, Ha-Eun Ryu, Taehwa Han, Byoungjin Park, Seok-Jae Heo, Yu-Jin Kwon Endocrine.2025; 88(3): 717. CrossRef
Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice Yu Mou, Yao Tang, Xiuyan Zheng, Xiang Liu, Xuemei Wu, Hongji Wang, Jie Zeng, Qing Rao, Yaacov Ben-David, Yanmei Li, Lei Huang Frontiers in Pharmacology.2025;[Epub] CrossRef
A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman Biomedicines.2025; 13(3): 644. CrossRef
The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies Renee Hernandez, Natasha S. Garcia-Rodriguez, Marco A. Arriaga, Ricardo Perez, Auwal A. Bala, Ana C. Leandro, Vince P. Diego, Marcio Almeida, Jason G. Parsons, Eron G. Manusov, Jacob A. Galan Frontiers in Medicine.2025;[Epub] CrossRef
Clinical Insights into Non-Alcoholic Fatty Liver Disease and the Therapeutic Potential of Flavonoids: An Update Aleksandra Kozłowska Nutrients.2025; 17(6): 956. CrossRef
Fat-1 Ameliorates Metabolic Dysfunction-Associated Fatty Liver Disease and Atherosclerosis through Promoting the Nuclear Localization of PPARα in Hamsters Wenxi Zhang, Jiabao Guo, Guolin Miao, Jingxuan Chen, Yitong Xu, Pingping Lai, Lianxin Zhang, Yufei Han, Sin Man Lam, Guanghou Shui, Yuhui Wang, Wei Huang, Xunde Xian Research.2025;[Epub] CrossRef
Acteoside inhibits hepatic lipid accumulation and oxidative stress in type 2 diabetic mice via the Nrf2/HO-1 Pathway Dan-Dan Hao, Lei Zhang, Si-Lin Liu, Zhi-Juan Sun, Ri-Gu-Leng Si, Feng-Ning Zhang, Li-Xin Yang, Xiao-Li Jia, Tian-Zhu Li, Lin Ai, Chun-Ying Bai, Kai Gu, Cong-Ying Zhang Journal of Toxicology and Environmental Health, Part A.2025; 88(15): 616. CrossRef
Therapeutic Potential of GLP-1 Receptor Agonists in Metabolic Associated Steatotic Liver Disease Klaudia Nowak, Krzysztof Łupina, Anna Romac, Aleksandra Kalisz, Łucja Ilkiewicz, Jakub Janczura Annals of Pharmacotherapy.2025; 59(10): 928. CrossRef
Association between oxidative stress and liver fibrosis severity in non-alcoholic fatty liver disease: insights from the pro-oxidant antioxidant balance method in a population from Tehran and Mashhad, Iran Hami Ashraf, Amir Anushiravani, Maryam Rayatpisheh, Daryoush Hamidi Alamdari, Arianaz Hossieni, Behrang Kazeminezhad Frontiers in Medicine.2025;[Epub] CrossRef
Fatty liver index and development of lung cancer: a nationwide cohort study Jihye Lim, Bongseong Kim, Kyungdo Han, Jeong Uk Lim The Korean Journal of Internal Medicine.2025; 40(2): 275. CrossRef
Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial Weijun Gu, Yibing Lu, Xinhua Ye, Guoyue Yuan, Dongmei Liu, Zewei Shen, Ning Zu, Yiming Mu Diabetes, Obesity and Metabolism.2025; 27(5): 2540. CrossRef
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang Clinical and Molecular Hepatology.2025; 31(Suppl): S228. CrossRef
Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease Tom Ryu, Seung Yun Chae, Jaejun Lee, Ji Won Han, Hyun Yang, Beom Sun Chung, Keungmo Yang Scientific Reports.2025;[Epub] CrossRef
Evaluating the Effectiveness of Pegbelfermin in MASH‐Associated Hepatic Fibrosis A Meta‐Analysis and Systematic Review of Randomized Controlled Trials Muhammad Shahzil, Fariha Hasan, Syeda Kanza Kazmi, Manesh Kumar Gangwani, UmmeSalma Shabbar, Ammad Javaid Chaudhary, Muhammad Ali Khaqan, Muhammad Saad Faisal, Kathy N. Williams, Babu P. Mohan, Christina Tofani JGH Open.2025;[Epub] CrossRef
Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017–2020 Xin Liao, Song Yu, Lin Wang, Ruyue Zhang, Ke Yu Frontiers in Physiology.2025;[Epub] CrossRef
Lean MASLD and Cardiovascular Disease: A Review Nachum Lebovics, Gabriel Heering, William H. Frishman, Edward Lebovics Cardiology in Review.2025;[Epub] CrossRef
Unlocking the Therapeutic Potential of Patchouli Leaves: A Comprehensive Review of Phytochemical and Pharmacological Insights Isack Ibrahim Mrisho, Elshan Musazade, Haobo Chen, Huixuan Zhao, Junjia Xing, Xue Li, Jiahong Han, Enbo Cai Plants.2025; 14(7): 1034. CrossRef
Identification of CACNB1 protein as an actionable therapeutic target for hepatocellular carcinoma via metabolic dysfunction analysis in liver diseases: An integrated bioinformatics and machine learning approach for precise therapy Jing Sun, Run Shi, Zhaokai Zhou, Weilong Xu, Jiaxuan Huai, Yutian Cao, Wenhui Zhang, Lijuan Nie, Gaoxiang Wang, Qianhua Yan, Xuanbin Wang, Minglun Li, Zhuyuan Fang, Xiqiao Zhou International Journal of Biological Macromolecules.2025; 308: 142315. CrossRef
Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease Goran Hauser, Indira Benjak Horvat, Mirjana Rajilić-Stojanović, Irena Krznarić-Zrnić, Michail Kukla, Vedrana Aljinović-Vučić, Ivana Mikolašević Biomedicines.2025; 13(4): 779. CrossRef
Neutrophils in MASLD and MASH Sanjeeb Shrestha, Jae-Han Jeon, Chang-Won Hong BMB Reports.2025; 58(3): 116. CrossRef
Prevalence and risk factors of metabolic-associated fatty liver disease in sub-Saharan Africa: a systematic review and meta-analysis Emmanuel M. Sindato, Violet Dismas Kajogoo, Gloria Ngajilo, Wondwossen Amogne Degu, Zahid Khan, Gideon Mlawa Frontiers in Gastroenterology.2025;[Epub] CrossRef
ROS Signaling Controls Lipid Accumulation in HepG2 Cells Driven by Doxorubicin-Induced Senescence Chawon Yun, Seung Jun Noh, Hamed Kazemi Zahrani, Sou Hyun Kim, Young-Suk Jung Drug Targets and Therapeutics.2025; 4(1): 1. CrossRef
Linghe granules reduces hepatic lipid accumulation in Non-alcoholic fatty liver disease through regulating lipid metabolism and redox balance Yuting Hu, Ni'ao Li, Rumian Zhang, Jia Wang, Dongdong Fang, Qianmei Zhou, Hua Zhang, Hong Cai, Yiyu Lu Phytomedicine.2025; 141: 156654. CrossRef
Spatial Viscoelastic Information in Metabolic Dysfunction–associated Steatotic Liver Disease Guilherme Moura Cunha Radiology.2025;[Epub] CrossRef
Radiomics in liver research: A paradigm shift in disease detection and staging Minh Huu Nhat Le, Hien Quang Kha, Nghia Minh Tran, Phat Ky Nguyen, Han H. Huynh, Phat Kim Huynh, Han Lam, Nguyen Quoc Khanh Le European Journal of Radiology Artificial Intelligence.2025; 2: 100016. CrossRef
MicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential Mei Tian, Yang Zhou, Yitong Guo, Qing Xia, Zehua Wang, Xinying Zheng, Jinze Shen, Junping Guo, Shiwei Duan, Lijun Wang Genes & Diseases.2025; 12(4): 101287. CrossRef
PREVALENCE AND RISK FACTORS ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON HYDROXYCHLOROQUINE: A POPULATION-BASED STUDY Antoine BOUSTANY, Somtochukwu ONWUZO, Adejoke JOHNSON, David FARHAT, Mimi NAJJAR, Hadi Khaled Abou ZEID, Chidera N ONWUZO, Mohamad-Noor ABU-HAMMOUR, Rashid ABDEL-RAZEQ, Islam MOHAMED, Barish EREN, Imad ASAAD Arquivos de Gastroenterologia.2025;[Epub] CrossRef
Effects of combined prebiotic fiber supplementation and weight loss counseling in adults with metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial Shyamchand Mayengbam, Maitreyi Raman, Jill A. Parnell, Bertus Eksteen, Jennifer E. Lambert, Lindsay K. Eller, Alissa C. Nicolucci, Michelle L. Aktary, Raylene A. Reimer European Journal of Nutrition.2025;[Epub] CrossRef
The Changing Pathogenesis of Liver Cancer in Hawaii over Three Decades Linda L. Wong, Larry R. Hromalik, Brenda Y. Hernandez, Jared D. Acoba, Sandi A. Kwee Cancer Epidemiology, Biomarkers & Prevention.2025; 34(4): 527. CrossRef
Association of serum uric acid-to-high-density lipoprotein cholesterol ratio with cardiovascular disease risk in patients with metabolic dysfunction-associated fatty liver disease: a cross-sectional NHANES analysis Xianyao Wang, Yuchen Shi, Ying Zi, Jun Long, Rongjie Shi Frontiers in Nutrition.2025;[Epub] CrossRef
Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD through the COVID-19 pandemic: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023” Jeayeon Park, Su Jong Yu Clinical and Molecular Hepatology.2025; 31(2): 625. CrossRef
Multiparametric MRI Including T1ρ Mapping for Hepatic Fibrosis Assessment in Preclinical Models of Steatotic Liver Disease Narine Mesropyan, Franziska Schneider, Pia C. Lutz, Christoph Katemann, Oliver M. Weber, Johannes M. Peeters, Tatjana Dell, Jennifer Lehmann, Claus C. Pieper, Daniel Kuetting, Christian P. Strassburg, Julian A. Luetkens, Johannes Chang, Alexander Isaak Investigative Radiology.2025; 60(10): 679. CrossRef
Robuvit® supplementation reduces progression of non-alcoholic fatty liver disease in elderly subjects Maria R. CESARONE, Gianni BELCARO, David COX, Giuseppe GIZZI, Luciano PELLEGRINI, Claudia SCIPIONE, Valeria SCIPIONE, Francesca COPPAZUCCARI, Mark DUGALL, Shu HU, Luciano ORSINI, Marcello CORSI, Beatrice FERAGALLI, Roberto COTELLESE Minerva Gastroenterology.2025;[Epub] CrossRef
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysis Jiajing Li, Jiahua Zhou, Pengfei Li, Yining Wang, Nathalie Ridderhof, Jaffar A. Al-Tawfiq, Willem Pieter Brouwer, Kan Chen, Robert J. de Knegt, Maikel P. Peppelenbosch, Bettina E. Hansen, Maarten F.M. Engel, Ming-Hua Zheng, Ziad A. Memish, Mohammed Eslam, Hepatology Communications.2025;[Epub] CrossRef
3-Fucosyllactose Prevents Nonalcoholic Fatty Liver Disease by Modulating the Gut Microbiota-Derived Pantothenate in Mice Bei Liu, Ningning He, Hui Li, Zizhen Yang, Yichen Lin, Xiaoyu Wu, Haoyan Zhang, Ziheng Zhang, Zishuai Zhang, Yu Tian, Zhinan Wu, Yuanqiang Zou, Jixing Peng, Shangyong Li Journal of Agricultural and Food Chemistry.2025; 73(16): 9637. CrossRef
The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study Yanjun Guo, Wei Su, Lulong Tao, Guoxin Zhang, Kun Wang BMC Gastroenterology.2025;[Epub] CrossRef
Biomarker-driven drug repurposing for NAFLD-associated hepatocellular carcinoma using machine learning integrated ensemble feature selection Subhajit Ghosh, Sukhen Das Mandal, Subarna Thakur Frontiers in Bioinformatics.2025;[Epub] CrossRef
Furan fatty acids supplementation in obese mice reverses hepatic steatosis and protects against cartilage degradation Mathys Chaslin, Georges Maroun, Erwann Durand, Béatrice Bonafos, Said Assou, Jatuporn Chaiyut, Laurent Vaysse, Vincent Ferrer, Siriluck Liengprayoon, Thomas Brioche, Laurence Pessemesse, Mélanie Macart, Christelle Bertrand-Gaday, Yves-Marie Pers, Charles Biomedicine & Pharmacotherapy.2025; 187: 118072. CrossRef
Recent advances in therapeutic probiotics: insights from human trials Mu-Yeol Cho, Je-Hyun Eom, Eun-Mi Choi, Seung-Jo Yang, Dahye Lee, Young Youn Kim, Hye-Sung Kim, Inseong Hwang, Christopher Staley Clinical Microbiology Reviews.2025;[Epub] CrossRef
Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study Jisuk Yun, Young‐Sun Min American Journal of Industrial Medicine.2025; 68(7): 588. CrossRef
Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J. Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones, Ricardo Gómez-Huelgas, Daniel de Luis, Idoia Genúa Trullos, Rocío Aller, Miguel A. Rub Gastroenterología y Hepatología.2025; 48(8): 502442. CrossRef
A novel ASGR1-Targeting nanocomplex for mitigating donor liver steatosis Xinwei Li, Yingying Liu, Deshu Dai, Huan Liu, Guangyao Zhang, Lianghao Zhang, Shangheng Shi, Peng Jiang, Bingliang Zhang, Zhiwen Zhao, Xuzhu Gao, Kun Yu, Qingguo Xu, Jinzhen Cai Chemical Engineering Journal.2025; 513: 163089. CrossRef
High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysis Glenn Jun Kit Ho, Faith Xin Ning Tan, N.Apoorva Sasikumar, Ethan Kai Jun Tham, Donghyun Ko, Do Han Kim, Pojsakorn Danpanichkul, Zhenning Yu, Cheng Xianda, Zi Xuan Zhang, Karn Wijarnpreecha, Thanawin Pramotedham, Mazen Noureddin, Daniel Q. Huang, Yoshio Su Clinical Gastroenterology and Hepatology.2025;[Epub] CrossRef
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors Jui-Hua Huang, Ren-Hau Li, Hon-Ke Sia, Feng-Cheng Tang Metabolites.2025; 15(5): 318. CrossRef
Maternal protein restriction compromises hepatic phenotype and antioxidant defense in postweaning male rats, while females exhibit resilience André Matheus Leandro Franzolin, Matheus Naia Fioretto, Isabelle Tenori Ribeiro, Flávia Alessandra Maciel, Luisa Annibal Barata, Pedro Menchini Vitali, Natália Magosso, Felipe Leonardo Fagundes, Maycon Tavares Emílio-Silva, Clélia Akiko Hiruma Lima, Welle Biochemical and Biophysical Research Communications.2025; 766: 151873. CrossRef
The safety and efficacy of acupuncture in treating nonalcoholic fatty liver disease: A systematic review and meta-analysis based on randomized controlled trials Chunhui Liu, Youguang Ao, Baixue Liu, Juan Huang, Qi Wang, Xiaojing Ao, Xiongyao Wang, Xiufeng Ban Medicine.2025; 104(18): e42272. CrossRef
Hepatoprotective Effect of Kaempferol—A Review Przemysław Niziński, Anna Krajewska, Tomasz Oniszczuk, Beata Polak, Anna Oniszczuk Molecules.2025; 30(9): 1913. CrossRef
Hepatocellular carcinoma risk in ICD-coded non-cirrhotic nonalcoholic fatty liver disease refined by fatty liver index: A nationwide South Korean cohort study Chang Hun Lee, Min Gu Kang, Shinyoung Oh, In Sun Goak, Chen Shen, Ha Ram Oh, Young Ran Park, Jong Seung Kim, Ji Hyun Park Clinics and Research in Hepatology and Gastroenterology.2025; 49(6): 102612. CrossRef
Comparison of Non-invasive Methods for Diagnosis of Non-alcoholic Fatty Liver Disease Before Bariatric Surgery and Postoperative Follow-up in Obese Patients Ji-Hyeon Park, Seong Min Kim, Dae Ho Lee Journal of Metabolic and Bariatric Surgery.2025; 14(1): 53. CrossRef
Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches Mohamed Zaiou, Olivier Joubert Biomolecules.2025; 15(5): 669. CrossRef
Heterogeneity of cardiometabolic and hepatic fibrosis risks in nonalcoholic fatty liver disease among lean, overweight, and obese populations: a multicenter cross-sectional study Lili Gao, Wujun Xiong, Yong Wang, Wei Wang, Xiaoliang Wang, Hao Zhang European Journal of Gastroenterology & Hepatology.2025; 37(8): 975. CrossRef
Ginsenoside Rh2 Mitigates Endoplasmic Reticulum Stress-Induced Apoptosis and Inflammation and Through Inhibition of Hepatocyte–Macrophage Inflammatory Crosstalk Shinjung Park, Inae Jeong, Ok-Kyung Kim Nutrients.2025; 17(10): 1682. CrossRef
Rutin‐Associated Hepatoprotection: A Review of Mechanisms and Therapeutic Prospects Yanting Feng, Lanchun Peng, Xiaohui Liu, Qingzhu Zheng, Min Qian, Meiling Deng, Jiangli Peng, Yamei Li, Limei Lin, Qiuxian Peng Basic & Clinical Pharmacology & Toxicology.2025;[Epub] CrossRef
A Comparison of the Effects of Milk, Yogurt, and Cheese on Insulin Sensitivity, Hepatic Steatosis, and Gut Microbiota in Diet-Induced Obese Male Mice Emad Yuzbashian, Dineli N. Fernando, René L. Jacobs, Till-Robin Lesker, Till Strowig, Siegfried Ussar, Catherine B. Chan International Journal of Molecular Sciences.2025; 26(11): 5026. CrossRef
Does Vitamin D Independently Lower the Severity of Nonalcoholic Fatty Liver Disease? A Case-Control Study in Khuzestan Province, Iran Zeinab Karimi, Zahra Shokati Eshkiki, Samira Mohammadi, Ahmad Nezhadisalami Jundishapur Journal of Natural Pharmaceutical Products.2025;[Epub] CrossRef
Hepatic stellate cell-specific Kcnma1 deletion mitigates metabolic dysfunction-associated steatotic liver disease progression via upregulating Amphiregulin secretion Yunhan Zou, Jiaoxiang Wu, Sheng Cheng, Daqing Cheng, Taoying Chen, Xirong Guo, Li Tang, Xianbin Su, Man Zhang, Xin Zhang, Ying Liu, Jin Zhang, Qun Bao, Shangwei Hou, Peng Sun, Yong Li, Bo Han Molecular Metabolism.2025; 97: 102164. CrossRef
In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model Anuththara Upamali Abeykoon, Madhavi Priyanka Paranagama, Kavindra Kumara Wijesundera, Onela Canith Pathirana, Thilini Anupama Mahakapuge, Jayantha Rajapakse BMC Complementary Medicine and Therapies.2025;[Epub] CrossRef
High-intensity interval training prevents high-fat diet-induced hepatic steatosis by modulating miRNA-34a, miRNA-467b, and their primary target proteins in male rats Amir Mohammad Zobeydi, Mohammad Reza Kordi, Reza Gharakhanlou, Hamidreza Khalounejad, Mohammad Parastesh Archives of Physiology and Biochemistry.2025; 131(5): 874. CrossRef
Recovery of Lysosomal Acidification and Autophagy Flux by Attapulgite Nanorods: Therapeutic Potential for Lysosomal Disorders Yuanjing Hao, Xinru Fan, Xiaodan Huang, Zhaoying Li, Zhiyuan Jing, Guilong Zhang, Yuxue Xu, Na Zhang, Pengfei Wei Biomolecules.2025; 15(5): 728. CrossRef
COMPARATIVE ANALYSIS OF METHODS FOR INDUCING STEATOSIS USING A COMPLEX OF FATTY ACID - BOVINE SERUM ALBUMIN IN AN IN VITRO MODEL ON HEPG2 CELLS E. Knyazeva, D. Vinokhodov Problems of Biological, Medical and Pharmaceutical Chemistry.2025; : 66. CrossRef
Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study) Viswanathan Mohan, Shashank Joshi, Saket Kant, Altamash Shaikh, L. Sreenivasa Murthy, Banshi Saboo, Parminder Singh, Aravind R. Sosale, Debmalya Sanyal, G. Shanmugasundar, Santosh Kumar Singh, A. K. Pancholia, Sunetra Mondal, Rishi George, Ashok Jaiswal, Diabetes Therapy.2025; 16(7): 1435. CrossRef
Statin use and risk of HCC in patients with MASLD and T2DM: an umbrella review and meta-analysis Nazanin Hosseinkhan, Laily Najafi, Soodeh Jahangiri, Zahra Emami, Mohammad E. Khamseh BMC Cancer.2025;[Epub] CrossRef
Serum Mac-2 binding protein glycosylation isomer as a biomarker for metabolic dysfunction associated steatotic liver disease Ahmed M. F. Mansour, Ehab Nashaat, Asmaa Gouda Seliem Hassan Mohamed, Ahmed Mohamed ElGhandour Egyptian Liver Journal.2025;[Epub] CrossRef
Assessing Knowledge, Attitudes, and Factors Influencing Nonalcoholic Fatty Liver Disease among Adults in Saudi Arabia Syed Shah Mohammed Faiyaz, Mubashir Zafar, S. Alharbi Meshal Jameel, Fahad Munawir G Alharbi, Alshaymaa Alameen Sayed Alameen, Syed Monowar Alam Shahid Asian Journal of Pharmaceutical Research and Health Care.2025; 17(1): 44. CrossRef
Global Burden of Chronic Liver Disease and Temporal Trends: A Population‐Based Analysis From 1990 to 2021 With Projections to 2050 Yunyu Zhao, Yajing Bo, Jian Zu, Zixuan Xing, Zhanpeng Yang, Yue Zhang, Yujiao Deng, Yi Liu, Lanting Zhang, Xiao Yuan, Yuan Wang, Linda Henry, Fanpu Ji, Mindie H. Nguyen Liver International.2025;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits Hala Abdallah, Mohamad Khalil, Ewa Awada, Elisa Lanza, Agostino Di Ciaula, Piero Portincasa European Journal of Internal Medicine.2025; 138: 101. CrossRef
Therapeutic Potential of Infrared and Related Light Therapies in Metabolic Diseases Agnieszka Nowacka, Maciej Śniegocki, Wojciech Smuczyński, Ewa Ziółkowska International Journal of Molecular Sciences.2025; 26(11): 5134. CrossRef
Efficacy of interventions with live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials Yutong Wu, Hao Wu, Hang Yi Frontiers in Pharmacology.2025;[Epub] CrossRef
Biological ageing mediates the associations between urinary metals and metabolic dysfunction-associated steatotic liver disease Yin-Ping Wu, Jin Feng, Yuan-Yuan Zhang, Bai-Yun Wu, Ze-Hua Zhao, Yu-Chen Fan Ecotoxicology and Environmental Safety.2025; 300: 118455. CrossRef
Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective Abdul Hamid Zargar, Anil Bhansali, Anirban Majumdar, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Damodarlal Saboo, Bipin Kumar Sethi, Debmalya Sanyal, Krishna G. Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Jitendra Lakhani, P Diabetes, Obesity and Metabolism.2025; 27(S4): 3. CrossRef
Advanced Microbiome Therapeutics Accelerate MASLD Recovery by Restoring Intestinal Microbiota Equilibrium and the Gut-Liver Axis in a Mouse Model Johnson Lok, Congjia Chen, Valeria Iannone, Ambrin Farizah Babu, Emily Kwun Kwan Lo, Ruben Vazquez-Uribe, Troels Holger Vaaben, Mikko Kettunen, Otto Savolainen, Ursula Schwab, Morten Otto Alexander Sommer, Kati Hanhineva, Marjukka Kolehmainen, Hani El-Nez Journal of Agricultural and Food Chemistry.2025; 73(24): 15199. CrossRef
Pyrimidinetrione benzodioxol ameliorates MAFLD-induced liver tumorigenesis and mood disorders in mice Fang-Yu Hsu, Wan-Chun Chiu, Fat-Moon Suk, Chun-Ya Lee, Ming-Hua Hsu, Yi-Jen Liao npj Gut and Liver.2025;[Epub] CrossRef
An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease Youngshim Choi, Yinyan Ma, Samson Tom, Alla Danilkovitch, Liqing Yu Frontiers in Bioengineering and Biotechnology.2025;[Epub] CrossRef
The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease Wenjing Liu, Xian Zhou, Liyu Xiao, Xiaolan Huang, Dennis Chang, Xiaomei Zhong, Minjie Zeng, Yanfang Xian, Yanfang Zheng, Wei Huang, Rui Huang, Mingqing Huang Chinese Medicine.2025;[Epub] CrossRef
Cornus officinalis Extract Ameliorates Fructose‐Induced Hepatic Steatosis in Mice by Sustaining the Homeostasis of Intestinal Microecology and Lipid Metabolism Liang Chen, Yingying Song, Yurou Huang, Junjie Hu, Yan Meng, Ming Yuan, Guohua Zheng, Xuanbin Wang, Cong Zhang, Zhenpeng Qiu Food Science & Nutrition.2025;[Epub] CrossRef
MAFLD as a Cardiovascular Risk Factor: An Extended Retrospective Study with a Control Group Małgorzata Szymala-Pędzik, Marcin Piersiak, Maciej Pachana, Karolina Lindner-Pawłowicz, Wioletta Szczepaniak, Małgorzata Sobieszczańska Journal of Clinical Medicine.2025; 14(12): 4181. CrossRef
The newly proposed dietary index for gut microbiota and its association with the risk of nonalcoholic fatty liver disease: the mediating role of body mass index Shengnan Meng, Luonan Li, Shijie Yin, Yuxuan Zhao, Yaning Liu, Yuxi Zhang, Xiaolin Zhang, Fengxue Yu Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Epidemiological trends and burden of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa region: a 32-year analysis of health impact Zahra Sarkoohi, Mohammad-Mahdi Bastan, Mohammad Amin Khajuei Gharaei, Mahsa Iranmanesh, Arya Adinepour, Reyhane Khajezade, Faegheh Bahri, Fatemeh Akhlaghi, Azin Kadkhodamanesh, Hossein Pourghadamyari, Hamid Sharifi, Omid Eslami, Seyed Aria Nejadghaderi Journal of Health, Population and Nutrition.2025;[Epub] CrossRef
Validation of the FibroScan-AST (FAST) and Agile 3+ score in metabolic dysfunction-associated steatotic liver disease in a Russian cohort of patients V. P. Gomonova, K. L. Raikhelson, V. A. Kashchenko, A. V. Lodygin, V. E. Karev Meditsinskiy sovet = Medical Council.2025; (8): 134. CrossRef
Therapeutic Potential of Ellagic Acid in Liver Diseases Karolina Wojtunik-Kulesza, Przemysław Niziński, Anna Krajewska, Tomasz Oniszczuk, Maciej Combrzyński, Anna Oniszczuk Molecules.2025; 30(12): 2596. CrossRef
Dosimetrically coupled multiscale tetrahedral mesh models of human liver vasculature: implications for radiopharmaceutical dosimetry of both organ blood and parenchyma Robert J Dawson, Carlos Huesa-Berral, Lukas M Carter, Chris Beekman, Chansoo Choi, Bangho Shin, Mislav Bobić, Nicolò Cogno, Julia D Withrow, Derek W Jokisch, Alejandro Bertolet, Harald Paganetti, Wesley E Bolch Physics in Medicine & Biology.2025; 70(12): 125016. CrossRef
Kupffer cell programming by maternal obesity triggers fatty liver disease Hao Huang, Nora R. Balzer, Lea Seep, Iva Splichalova, Nelli Blank-Stein, Maria Francesca Viola, Eliana Franco Taveras, Kerim Acil, Diana Fink, Franzisca Petrovic, Nikola Makdissi, Seyhmus Bayar, Katharina Mauel, Carolin Radwaniak, Jelena Zurkovic, Amir H. Nature.2025; 644(8077): 790. CrossRef
Prevalence, risk factors, quality of life, and awareness of MASLD among Egyptian university students: a cross-sectional study Mohamed El-Kassas, Marwa Romeih, Abobakrelsedik Fangary, Ali Abouelyazeed, Islam Abdelfattah, Aya Alerian, Ahmed Ekbal, Yosra Abdelsalam Elshaikh, Samar Abbas, Marwa Tahoon, Hanaa Nagdy, Mohamed Elbadry Egyptian Liver Journal.2025;[Epub] CrossRef
Chitosan lactate mitigates metabolic-associated fatty liver disease via TGR5-mediated anti-inflammatory mechanisms and the gut-hepatic-bile acid axis Yiyu Lin, Weijun Lun, Yan Bai, Qishi Che, Hua Cao, Jiao Guo, Zhengquan Su Journal of Functional Foods.2025; 131: 106946. CrossRef
Laminin γ2 accelerates non-alcoholic fatty liver disease progression by enhancing lipid accumulation and fibrogenesis in hepatocytes Hui Chen, Guanggang Meng, Aiting Yang Biochemical and Biophysical Research Communications.2025; 777: 152266. CrossRef
Changes in liver function markers and lipid profile of rats administered rainy and dry season Amaranthus spinosus methanol extract and lead acetate Endurance Fegor Isoje, Israel Oghenevwodokohwo Okoro, Augustine Apiamu, Joel Okpoghono Food Chemistry Advances.2025; 8: 101049. CrossRef
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Javier Crespo, Juan J. Mascort, Ignacio Aguilar, Francisco Tinahones, Pedro Cañones, Ricardo Gómez-Huelgas, Daniel de Luis, Idoia Genúa Trullos, Rocío Aller, Miguel A. Rub Gastroenterología y Hepatología (English Edition).2025; 48(8): 502442. CrossRef
Study of association and diagnostic utility of novel anthropometric and lipid indices for nonalcoholic fatty liver disease: A hospital-based study Anand K. Pyati, Sakthivadivel Varatharajan, Abhishek Arora, Vaman Kulkarni, Aparna Varma Bhongir, Sangeetha Sampath, Gomathi Ramaswamy, Madhu Latha Karra, Priyanka Das, Pawan Pagaku Journal of Family Medicine and Primary Care.2025; 14(6): 2365. CrossRef
Exogenous H2S reduces oxidative stress induced by lipid mixture in HepG2 cells through USP22/SIRT1 axis Xiaomeng Cui, Chengjun Li, Shuixiang He, Yarui Li Scientific Reports.2025;[Epub] CrossRef
Genetic algorithm-back propagation artificial neural network model- and response surface methodology-based optimization of crude Lophatherum gracile Brongn. polysaccharides extraction and their anti-NAFLD effects via regulating liver-adipose tissue crosst Chao Wu, Qi-Cong Chen, Qian Ni, Wei-Feng Cai, Cui-Ping Jiang, Yan-Kui Yi, Li Liu, Chun-Yan Shen International Journal of Biological Macromolecules.2025; 320: 145806. CrossRef
The Rising Global Burden of MASLD and Other Metabolic Diseases (2000–2021) Pojsakorn Danpanichkul, Kanokphong Suparan, Luis Antonio Diaz, Michael B. Fallon, Vincent L. Chen, Kornnatthanai Namsathimaphorn, Krittameth Rakwong, Torlap Inkongngam, Chuthathip Kaeosri, Markos Kalligeros, Phuuwadith Wattanachayakul, Cheng Han Ng, Hirok United European Gastroenterology Journal.2025; 13(7): 1141. CrossRef
U-shaped association of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with NAFLD: results from the NHANES database prospective cohort study Yitian Dong, Jiayuan Ye, Hui Li, Weiliang Kong, Guoqing Qian, Yilian Xie BMC Gastroenterology.2025;[Epub] CrossRef
High sensitivity C-reactive protein may be a significant predictor of non-alcoholic fatty liver disease in non-obese adults: A four-year retrospective study Changxi Chen, Jiande Gong, Mengting Li, Shiyu Pan, Guitao Xia, Yuemei Xu, Hongliang Li, Qi Lin Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(12): 104224. CrossRef
Comment on “G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression” Abdullah K. Malik, Derek A. Mann Transplantation.2025; 109(10): e623. CrossRef
Liver transplant volume association with presence of heart and lung transplant programs: analysis of SRTR metrics Sanath Patil, Faizaan Siddique, Daler Rahimov, Keshava Rajagopal, John W. Entwistle, Adam Bodzin, Vakhtang Tchantchaleishvili General Thoracic and Cardiovascular Surgery.2025;[Epub] CrossRef
Non-invasive detection of fibrosis in non-alcoholic fatty liver disease by serum microfibrillar-associated protein 4 and its correlation with FIB-4 and transient elastography Heba Abdel Rahman Eltony, Gamal Kasem, Radwa Mahmoud Elsharaby, Rehab Badawi, Eman M. Helal Egyptian Liver Journal.2025;[Epub] CrossRef
Ultra-processed foods and non-alcoholic fatty liver disease: an updated systematic review and dose–response meta-analysis Jinghong Zhang, Long Shu, Xiaopei Chen Frontiers in Nutrition.2025;[Epub] CrossRef
Epigenetic modifications in the murine liver upon depletion of transcriptional coregulator host cell factor 1 Shruti Kaushal, Debashruti Bhattacharya, Saran Kumar, Winship Herr, Jaspreet Kaur Dhanjal, Shilpi Minocha BMC Genomics.2025;[Epub] CrossRef
Higher afamin concentrations are associated with higher fatty liver indices: Population‐based KORA F4/FF4 study Corinna Niersmann, Anna Zhu, Haifa Maalmi, Xinting Cai, Jana Nano, Wolfgang Rathmann, Wolfgang Koenig, Toshinari Takamura, Barbara Kollerits, Hans Dieplinger, Annette Peters, Michael Roden, Florian Kronenberg, Barbara Thorand, Christian Herder European Journal of Clinical Investigation.2025;[Epub] CrossRef
In-vivo liver proton density fat fraction quantification at 0.55 T: a pilot study with comparison against 3 T MRI Rochelle E. Wong, Bilal Tasdelen, Ye Tian, Darryl Hwang, Sophia X. Cui, Liyun Yuan, Krishna S. Nayak Magnetic Resonance Materials in Physics, Biology and Medicine.2025; 38(6): 949. CrossRef
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park Cardiovascular Diabetology.2025;[Epub] CrossRef
Metals in the human liver: An underappreciated risk factor of hepatic insulin resistance and associated pathophysiology Rahul Kumar, Ashwin Chinala, Dhruv Grandhe, S. Joseph Endicott, Marcus A. Garcia, Matthew J. Campen, Rama R. Gullapalli Environmental Pollution.2025; 383: 126844. CrossRef
Prevalencia e importancia de la enfermedad periodontal en pacientes con enfermedad hepática esteatósica asociada a disfunción metabólica (MASLD) en Veracruz L. Roesch-Ramos, D.N. Guzmán-Uzcanga, S. Nolasco-Polito, S. Pérez-Pérez, F. Moreno-Marín, R.M. Francisco, H.R. Ordaz-Álvarez, F.B. Roesch-Dietlen, J.M. Remes-Troche, A.D. Cano-Contreras Revista de Gastroenterología de México.2025;[Epub] CrossRef
Metabolic traits as mediators between excess salt intake and the risk of nonalcoholic fatty liver disease Rui Li, Kaitai Hu, Lei Cui, Shiyi Sun, Yinghai Xie Medicine.2025; 104(29): e42715. CrossRef
Linarin alleviates high-fat diet-induced hepatic steatosis by inhibiting PDE4D and activating the cAMP/PKA/CREB pathway Yang Xiao, Jiale Wang, Hao Zhang, Xingzhen Yang, Jinfeng Zhou, Yunpeng Zhou, Siqi Liu, Mengkuan Liu, Yi Wang, Yang Wang, Qichao Liao, Menglong Hou, Yi Hao, Shi Liu, Zupeng Luo, Shuang Zhang, Jingsu Yu, Lin Yu, Lei Zhou, Yixing Li, Gaopeng Li Free Radical Biology and Medicine.2025; 239: 116. CrossRef
Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review Francisco Aguirre, Mayalen Valero-Breton, Daniel Cabrera, Luis Peñailillo, María Carolina Otero, Claudia Fredes, Claudio Cabello-Verrugio European Journal of Translational Myology.2025;[Epub] CrossRef
The association between metabolic-associated fatty liver diseases and risk of colorectal polyps, neoplasia, and cancer: A systematic review and meta-analysis of over 56 million individuals Amir Azimi, Amir Ghaffari Jolfayi, Vida Rezayifar, Fatemeh Ateen, Hanie Hosseini Fard, San Khasraw Mohammed Mohammed, Hale Hosseinizadeh, Sanam Faizabadi, Ali Keshavarzian, Mohammad Ali Mansournia, Massoud Vosough, Mohammad Rahmanian Clinics and Research in Hepatology and Gastroenterology.2025; 49(8): 102652. CrossRef
Novel thyroid hormone receptor-β1 agonist in the treatment of MASH Andrew Overholser, Eric Czech JAAPA.2025; 38(8): 6. CrossRef
Impact of Pathological Grades of Metabolic Dysfunction-Associated Steatotic Liver Disease on Weight Loss Following Laparoscopic Sleeve Gastrectomy Yun-Fei Qu, Kang Wang, Yue Li, Yu-Gang Cheng, San-Yuan Hu, Ming-Wei Zhong Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 2547. CrossRef
Albumin Reduces Hepatic Steatosis and Inflammation in High-Fat-Diet-Fed Mice Claire Rennie, Sheila Donnelly, Kristine McGrath International Journal of Molecular Sciences.2025; 26(15): 7156. CrossRef
Development and validation of a non-invasive prediction model for identifying high-risk children with metabolic dysfunction-associated fatty liver disease Yuan Xiaowu, Dong Jian, Wen Yizhu, Ma Ting, Tong Jin, Wei Juan, Wang Sirui, Wang Jinli, He Yuchen, Zhao Huan, Cheng Yuhang, Li Jun Frontiers in Pediatrics.2025;[Epub] CrossRef
One-carbon Metabolism and Epigenetic Elements are Modulated by miR-1914-5p in an in Vitro Model of Steatosis Camila Cristiane Pansa, Ana Caroline Pimentel de Oliveira, Karen C.M. Moraes Cell Biochemistry and Biophysics.2025;[Epub] CrossRef
MetALD: new insights and unraveling therapeutic potential Yue Feng, PanShiLi Han, Tao Liu, YanHang Gao Metabolism and Target Organ Damage.2025;[Epub] CrossRef
Potential Synergistic Effects of Caffeine and Naringin on Mitochondrial Biogenesis and Hepatic Steatosis in Adult Male Rats With NAFLD Induced by a High‐Fat Diet Mehrasa Azizollahi, Zahra Nasehi, Maryam Derakhshan, Fouzieh Zadhoush, Rossana C. Zepeda BioMed Research International.2025;[Epub] CrossRef
Mechanisms of metabolic-associated fatty liver disease induced by 48-week PCB138 exposure and theabrownin intervention Jianrong Han, Changqian Liu, Zhiyuan Chen, Fengkai Ruan, Fanzheng Xue, Lingxiao Ye, Yi Yu, Zhenghong Zuo, Chengyong He Environment International.2025; 203: 109780. CrossRef
Collagen peptides from Skipjack tuna (Katsuwonus pelamis) bones: Composition, characterization, and mechanism of high-fat diet-induced NAFLD amelioration Yu-Lin Jiang, Shuang-Yi Zhang, Bin Wang, Yu-Hui Zeng, Li Xu, Chang-Feng Chi Food Research International.2025; 219: 117114. CrossRef
The Role of Traditional Chinese Medicine in the Management of Nonalcoholic Fatty Liver Disease: Targeting Gut Microbiome Yifan Zhang, Hongkun Li, Na Jiang, Qingjing Ru The American Journal of Chinese Medicine.2025; 53(07): 2103. CrossRef
Exercise-Induced Changes in Enterohepatic Communication Are Linked to Liver Steatosis Resolution Yong Zou, Jie Xia, Sen Zhang, Yingjie Guo, Weina Liu, Zhengtang Qi Nutrients.2025; 17(18): 2962. CrossRef
Diet and Non-Alcoholic Fatty Liver Disease (NAFLD): Advances and Management Strtegies : A Comprehensive Review Syeda Farha S, Sheetal R Journal of Community Medicine and Public Health Research.2025; 6(1): 110. CrossRef
Fetuin-A as a Link Between Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes: A Metabolic Insight for Clinical Practice Oana Irina Gavril, Cristina Andreea Adam, Theodor Constantin Stamate, Radu Sebastian Gavril, Madalina Ioana Zota, Alexandru Raul Jigoranu, Andrei Drugescu, Alexandru Dan Costache, Irina Mihaela Esanu, Lidia Iuliana Arhire, Mariana Graur, Florin Mitu Biomedicines.2025; 13(9): 2098. CrossRef
Myristica fragrans houtt. Aqueous extract attenuates metabolic dysfunction-associated steatotic liver disease by targeting bile acid-gut microbiota axis Jiayin Qiu, Bo Zhang, Ke Song, Gang Wang, Jianxin Zhao, Hao Zhang, Xiaohua Chen Food Bioscience.2025; 72: 107493. CrossRef
Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK/SIRT1 and Nrf2/HO-1 signaling pathway Qingxia Shen, Junqian Wang, Na Yao, Xiyan Niu, Mi Liu, Xiaohui Li Acta Cirúrgica Brasileira.2025;[Epub] CrossRef
Exploring The Impact of Dietary and Metabolic Risk Factors on Non-Alcoholic Fatty Liver Disease (NAFLD) : A Cross-Sectional Study İzel Aycan Orakçı, İlyas Tuncer, Fatma Esra Güneş Turkish Journal of Health Science and Life.2025; 8(2): 29. CrossRef
The relationship between shift work and steatotic liver disease associated with metabolic dysfunction (MASLD): a systematic scoping review Virgínia S. D. Oliveira, Sara Montagnese, Claudia R. C. Moreno Journal of Public Health.2025;[Epub] CrossRef
Integrated untargeted metabolomics and network pharmacology reveal the active components and mechanisms of Astragalus against non-alcoholic fatty liver disease Zhentao Yao, Qiong Yu, Jiaxin You, Nuobei Zhang, Xiaojun Zhou, Tarek Gamal Abedelmaksoud, Yixin Zou, Wenjiao Ding, Zheng Ruan Food Bioscience.2025; 72: 107518. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes a Distinct Semaphorin–Cytokine Immune Signature in Severe Community-Acquired Pneumonia Branimir Gjurašin, Leona Radmanić Matotek, Lara Šamadan Marković, Neven Papić International Journal of Molecular Sciences.2025; 26(16): 8095. CrossRef
Coffee for the liver: a mechanistic approach Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Linda Vanessa Márquez-Quiroga, Karla Jocelyn Ortega-Carballo, Pablo Muriel Biochemical Pharmacology.2025; 242: 117338. CrossRef
Characteristics of Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Risk for Hepatic Fibrosis in 476,124 Korean Adults: A Cross-Sectional Study Da Yeon Lee, Ji-Hee Ko, Han-Na Jang, Sun Joon Moon, Hye-Mi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Eun-Jung Rhee Endocrinology and Metabolism.2025; 40(4): 648. CrossRef
Evaluation of photon-counting CT-derived attenuation parameters for noninvasive liver fat assessment Dingbo Shu, Jianping Wang, Ding Liang, Zhenhua Zhao, Jianfeng Yang European Journal of Radiology.2025; 191: 112354. CrossRef
Global, regional, and national burden of nonalcoholic fatty liver disease (NAFLD) among people aged 15 to 49 years from 1990 to 2021, with projections to 2050: A systematic analysis based on the 2021 global burden of disease study Mengqin Wang, Qiqige Wuyun, Dongbo Lian, Guangzhong Xu, Guangyi Zhu, Nengwei Zhang Medicine.2025; 104(37): e44527. CrossRef
Future potential therapeutics to treat MASH Shriram Mahajan, Navya Malladi, Sanjay K. Banerjee Drug Discovery Today.2025; 30(9): 104451. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes Ankita Dua, Rashmi Kumari, Mona Singh, Roushan Kumar, Sunila Pradeep, Akinyemi I. Ojesina, Roshan Kumar Frontiers in Medicine.2025;[Epub] CrossRef
Markers of body fat, the mediating role of alanine aminotransferase, and their association with the risk of metabolic dysfunction-associated steatotic liver disease Yuanyuan Li, Ruiping Liu, Yao An, Fangyuan He European Journal of Pediatrics.2025;[Epub] CrossRef
In Situ Imaging of Extracellular Vesicles and Non-Alcoholic Fatty Liver Disease with a Near-Infrared Fluorescent Viscosity Probe Zhijie Li, Qianhua Li, Yijia Liu, Yao Chen, Jinzheng Zhang, Haiyan Zhang, Guoqiang Feng Analytical Chemistry.2025; 97(35): 19186. CrossRef
Hepatic miRNA Expression Pattern and Changes in Lipid Metabolism-Related Genes in Mice Fed a High-Fat Diet for 16 Weeks Ahmet Cumaoğlu, Güzide Şatir Başaran Iranian Journal of Science.2025;[Epub] CrossRef
In Silico Study of Natural Polyphenols as Potential Metabolic Modulators in Mitigating Lipotoxicity in Non-Alcoholic Fatty Liver Disease via Thyroid Hormone Receptor Alpha Activation Evangelia K. Konstantinou, Athanasios A. Panagiotopoulos, Maria Dimitriou Current Issues in Molecular Biology.2025; 47(9): 777. CrossRef
Prevalence of Controlled Attenuation Parameter (CAP)-Assessed Hepatic Steatosis as a Possible Indicator of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Risk in Healthy Medical Students: A Cohort Study From South India Geeta S Desai, Sachi Hajare, Sandesha Ghorpade, Santosh Hajare Cureus.2025;[Epub] CrossRef
Novel obesity and metabolic indices better predict non-alcoholic fatty liver disease in elderly T2DM patients: evidence from cross-sectional and longitudinal analysis Mingjie Xu, Yushuang Wei, Lingyu Ye, Boteng Yan, Shengzhu Huang, Zengnan Mo, Mingli Li Frontiers in Medicine.2025;[Epub] CrossRef
A Systematic Review and Meta-Analysis of Cannabis Use Frequency and Metabolic Dysfunction-Associated Steatotic Liver Disease: Scapegoat or Healer? Néstor Israel Quinapanta Castro, Abdel Bermúdez-del Sol Cureus.2025;[Epub] CrossRef
Matcha Green Tea Improves Cafeteria-Diet-Induced NAFLD by Modulating the Gut Microbiota in Rats Ho-Ching Chong, Shu-Ting Tang, Yu-Chieh Tseng, Suh-Ching Yang, Yasuo Watanabe, Shizuo Yamada, Yu-Chen S. H. Yang, Ya-Ling Chen Nutrients.2025; 17(19): 3051. CrossRef
Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis—a cross-sectional study Tatjana Zekić, Filip Blažić, Nataša Katalinić, Nada Starčević Čizmarević, Aleksandar Čubranić Rheumatology International.2025;[Epub] CrossRef
Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH Xiaodong Yu, Chenyuan Huang, Martijn Evers, Jingjing Liu, Hui Jun Ting, Sitong Zhang, Suet Yen Chong, Michelle Siying Tan, Siyu Wang, Nilofer Sayed, Liang Gao, Mark D. Muthiah, Gwyneth S. T. Soon, Aileen Wee, Edward Kai-Hua Chow, Natalie Jun Hui Soh, Gior Science Advances.2025;[Epub] CrossRef
ANTIFIBROTIC STRATEGY IN THE TREATMENT OF CHRONIC LIVER DISEASES Mariana M. Seliuk, Anatolii M. Pechinka Ukrainian educational and scientific medical space.2025; (1): 28. CrossRef
The Effect of Intensive Combined Exercise on the Lipid Profile and Hepatic Enzymes in Modeling Diet-Induced NAFLD Rats Seyed Ali Mirghani, Mania Roozbayani, Saleh Rahmati, Lida Moradi Chonnam Medical Journal.2025; 61(3): 116. CrossRef
Association Between Whole Blood Iron and Nonalcoholic Fatty Liver Disease in Elderly: A Case–Control Study Zhe-Ying Jiang, Wei-Jia Meng, Ying Wang, Hua-Qin Su, Bi-Xiu Mao, Cai-Li Wang, Feng-Lian Peng, Cui-Ping Li, Lian-Ping He Biological Trace Element Research.2025;[Epub] CrossRef
Beneficial effects of probiotic supplementation (Lactiplantibacillus plantarum Dad-13) on body weight, liver function, and liver histopathological features in non-alcoholic fatty liver disease (NAFLD) model Sprague-Dawley rats Rahmawati MINHAJAT, Hanan AFIFAH, Husni CANGARA, Mirna MUIS, Agussalim BUKHARI, Sitti WAHYUNI Bioscience of Microbiota, Food and Health.2025; 44(4): 290. CrossRef
Prevalence and effect of PNPLA3 and TM6SF2 gene polymorphism on the course of non-alcoholic fatty liver disease N. S. Branovitskaya, A. L. Kalinin, A. A. Kovalev, M. N. Yatsuk, E. A. Lipskaya Health and Ecology Issues.2025; 22(3): 66. CrossRef
PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways David J. Sherman, Lei Liu, Edward L. LaGory, Preston Fordstrom, Danielle Pruitt, Jose Barreda, Joy G. Cagmat, Jiansong Xie, John Ferbas, Ingrid C. Rulifson, Raymond J. Deshaies Cell Reports.2025; 44(10): 116371. CrossRef
Metabolic Dysfunction–Associated Steatotic Liver Disease in Pregnancy Hannah W. Han, Peter S. Marcus, Tse-Ling Fong Obstetrical & Gynecological Survey.2025; 80(10): 647. CrossRef
Combined effect of metformin and ezetimibe on PPAR-γ and adiponectin gene expression and biochemical parameters in MAFLD patients with type 2 diabetes Asiyeh Masaeli, Mohammad Taghi Goodarzi, Adel Mohammadalipour, Safa Ali-Asgari, Mohammad Reza Mirzaei, Mohsen Hani Scientific Reports.2025;[Epub] CrossRef
Heme Oxygenase-1 Expression as a Prognostic Marker in Early-Stage HCC Undergoing Resection or Liver Transplantation Ramona Cadar, Alin Mihai Vasilescu, Ana Maria Trofin, Alexandru Grigorie Nastase, Mihai Zabara, Cristina Muzica, Corina Lupascu Ursulescu, Mihai Danciu, Andrei Pascu, Iulian Buzincu, Delia Ciobanu, Ianole Victor, Cristian Dumitru Lupascu Life.2025; 15(10): 1589. CrossRef
Association Between Non-Alcoholic Fatty Liver Disease and Subclinical Atherosclerosis: A Study of Carotid Intima-Media Thickness Maryam Issa Al-Ani, Huda Hameed Salman, Shaymaa Khalid Abdulqader, Nabeeha Najatee Akram, Ghasaq Ma'an Bakr Bakr Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ).2025; 9(2): 103. CrossRef
Health Status and Trends among Scientific Researchers in a City of Anhui Province, China, 2019~2024 玉玲 江 Statistics and Application.2025; 14(10): 73. CrossRef
Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study Catherine Behzad, Zainab Shateri, Nima Motamed, Mansooreh Maadi, Hossein Ajdarkosh, Elham Sobhrakhshankhah, Farhad Zamani, Azam Doustmohammadian, Mehran Nouri BMC Gastroenterology.2025;[Epub] CrossRef
Risk of Nephrolithiasis in Cirrhosis: A Comparison between MASLD Cirrhosis and Cirrhosis Due to Other Etiologies Sarpong Boateng, Mayssaa Hoteit, Prince Ameyaw, Simran Joshi, Alexa Plato, Rofina Johnkennedy, Donghyun Ko, Abhiraj Patel, Frances Mejia, Cheng-Hung Tai, Basile Njei, Gregory Buller Southern Medical Journal.2025; 118(9): 606. CrossRef
Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance Nicole Shu Ying Tang, Shyna Gunalan, Christen En Ya Ong, Benjamin Koh, Ethan Kai Jun Tham, Ryan Yanzhe Lim, Darren Jun Hao Tan, Nicholas Syn, Cheng Han Ng, Mark Muthiah, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Masahito Nakano, Asako Nogami, Atsushi Na Alimentary Pharmacology & Therapeutics.2025;[Epub] CrossRef
Preclinical and clinical evidence of xanthine oxidase inhibitors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis Steven Alvianto, Yovita Gotama, Antoninus Hengky, Nicolas Daniel Widjanarko, Mario Stefanus Egyptian Liver Journal.2025;[Epub] CrossRef
Predicting carotid plaques in metabolic dysfunction-associated steatotic liver disease using machine learning and SHAP interpretation Shu-Mei Zhai, Xiao-Long Wang, Han Zhang, Yu-Qiang Zuo Scientific Reports.2025;[Epub] CrossRef
Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease: An Updated Global Systematic Review and Meta-Analysis of over 1.5 Million Individuals Narsimha Keetha Rao, Shahriar Ghodous, Anoop Gurram, Mehrdad Khorasani, Madhusudhan Ponnala, Arman Habibi, Kwame Agyeman, Parsa Saberian, Pubali Biswas, Negin Letafatkar, Simran Joshi, Yasmin Sahli, Reza Amani-Beni, Bahar Darouei, Yussif Issaka, Kiran San Inflammatory Bowel Diseases.2025;[Epub] CrossRef
A proteome-wide association study reveals novel plasma proteins as potential therapeutic targets for metabolic dysfunction-associated steatotic liver disease Qian Zhong, Yue Zhu, Yiwen Tan, Wenzeng Deng, Chunxia Wang, Shan Yang, Nanwei Tong Frontiers in Endocrinology.2025;[Epub] CrossRef
The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what’s different? Priyankar Dey Frontiers in Endocrinology.2025;[Epub] CrossRef
Positive Association of the Dietary n-6/n-3 PUFA Ratio with Fatty Liver in Mexican Adults Cristina Gutierrez-Osorio, Omar Ramos-Lopez Healthcare.2025; 13(21): 2679. CrossRef
Liver Fat Quantification and Steatosis Grading in Fatty Liver Disease by Magnetic Resonance Imaging: Systematic Review and Meta‐Analysis Layan I. Al‐Huneidi, Feng Zhao, Romy Maas, Sven J. E. Ermans, Jurgen Runge, Xiangbai Chen, Jim X. Ji, Lejla Alic Journal of Gastroenterology and Hepatology.2025;[Epub] CrossRef
From traditional metabolic markers to ensemble learning: comparative application of machine learning models for predicting NAFLD risk in adolescents Chenming Zhang, Bin Niu, Rong Wang, Liaoyun Zhang Frontiers in Endocrinology.2025;[Epub] CrossRef
Maternal postpartum sedentary life exacerbates the metabolic impact of moderately fat-rich diet in male mice Katherine Lopez, Madelyn R. Baker, Qiuying Chen, Michele Alves-Bezerra, Baran Ersoy, Judit Gal Toth, Sandeep S. Reddy, Faten Taki, Rose Sciortino, David E. Cohen, Steven Gross, Miklos Toth npj Metabolic Health and Disease.2025;[Epub] CrossRef
Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice Zachary J. Fennel, Anu S. Kurian, Paul‐Emile Bourrant, Chad M. Skiles, Robert J. Castro, Elena M. Yee, Scott A. Greilach, Hans S. Keirstead, Gabriel Nistor, Nicole C. Berchtold, Thomas E. Lane, Micah J. Drummond Obesity.2025;[Epub] CrossRef
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer Gayle S. Jameson, S. Danielle LeGrand, Michael S. Gordon, Denise J. Roe, Betsy C. Wertheim, Kellen Olszewski, Josh Rabinowitz, Ron Evans, Michael Downes, Morgan Truitt, Ron Korn, Haiyong Han, Richard M. Miller, Michael T. Barrett, David Propper, Daniel D. Redox Biology.2025; 88: 103895. CrossRef
The ‘Obesity First’ approach: Redefining the future of healthcare Chris J. J. Mulder, Ahmed B. Bayoumy, Azhar R. Ansari Indian Journal of Gastroenterology.2025;[Epub] CrossRef
Mutation–selection–drift balance models of complex diseases Jeremy J Berg, Xinyi Li, Kellen Riall, Laura K Hayward, Guy Sella, A Long GENETICS.2025;[Epub] CrossRef
Opportunistic hepatic steatosis assessment in low-dose coronary artery calcium CT using liver adipose-radiomic index (LARI) Gourav Modanwal, Rohan Dhamdhere, Sanjay Rajagopalan, Jonathan Walker, Amit Khera, James A. de Lemos, Ronald Peshock, Jeffrey Browning, Parag Joshi, Ian J. Neeland, Sadeer Al-Kindi, Anant Madabhushi eBioMedicine.2025; 121: 105982. CrossRef
Liver fibrosis as a major prognostic factor in chronic liver diseases and a key target for pharmacotherapy S. N. Mekhtiev, O. A. Mekhtieva, O. M. Berko, A. S. Lovitskiy Meditsinskiy sovet = Medical Council.2025; (15): 126. CrossRef
Information Deficits, Information Needs, and Preferences Regarding eHealth in a Dutch Population With Metabolic Dysfunction–Associated Steatotic Liver Disease: Cross-Sectional Survey Study Sharon Oude Veldhuis, Maureen M J Guichelaar, Marjolein E M den Ouden, Lisette J E W C van Gemert-Pijnen, Constance H C Drossaert JMIR Formative Research.2025; 9: e78536. CrossRef
Prevalence and Risk Factors of Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh JMIR Diabetes.2025; 10: e77772. CrossRef
Targeting metabolic dysfunction-associated steatotic liver disease with phytosomal silymarin and piperine: A natural alternative to fenofibrate in a rat model Magdy Fouad Tawfik, Yasmin Sayed Hussein, Amany Helmy Hasanin, Walaa Baher, Nashwa El-Khazragy, Farouk Guindi Moawad, Mawada Abou El-Khair, Salwa M. El-Sayed Naunyn-Schmiedeberg's Archives of Pharmacology.2025;[Epub] CrossRef
Quantitative assessment of hepatic steatosis by ultrasound-guided attenuation parameter in patients with impaired glucose tolerance Ruixia Gao, Jiahao Han, Danlei Song, Pingping Wang, Huihui Chen, Huiming Shen, Jia Li Insights into Imaging.2025;[Epub] CrossRef
Mistakes in the utilization of vibration-controlled transient elastography in the evaluation of liver fibrosis: a narrative review Madunil Anuk Niriella, Uditha Bandara Dassanayake, Charith Priyanga Madurapperuma, Indeewari Prathibha Wijesingha, Arjuna Priyadarshin De Silva, Hithnadura Janaka de Silva Expert Review of Gastroenterology & Hepatology.2025; : 1. CrossRef
The Potential Role of Serum Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) as a Biomarker of Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Aalia Tahseen, Suchitra Kumari, Manaswini Mangaraj, Manas K Panigrahi Cureus.2025;[Epub] CrossRef
Prevalence of Liver Steatosis and Fibrosis Assessed by Transient Elastography in a High Cardiovascular-Risk Outpatient Cohort Including T1DM and T2DM Patients Alina N. Saidi, Willy B. Theel, Diederick E. Grobbee, Aart-Jan van der Lely, Femme Dirksmeier-Harinck, Marco Alings, Ellen van der Zwan-van Beek, Simone P. Rauh, Moniba Rasheed, Manuel Castro Cabezas Diabetology.2025; 6(11): 129. CrossRef
A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease Qing Peng, Liyuan Hao, Shenghao Li, Fei Yu, Na Li, Xiaoyu Hu Frontiers in Pharmacology.2025;[Epub] CrossRef
Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction–associated Steatotic Liver Disease: Radiologists’ Perspective Eri G. Osta, Florentino Saenz Rios, Sriram Jaganathan, Courtney Thomas, Eugenia Tsai, Venkateswar Surabhi, Srinivasa R. Prasad, Venkata S. Katabathina RadioGraphics.2025;[Epub] CrossRef
Chlorogenic Acid–Gut Microbiota Interactions: New Insights for Alleviating Chronic Diseases and Health Disorders Hui Kong, Juanjuan Han, Xin Meng, Xiaodong Wang, Xin-an Zhang Nutrition Reviews.2025;[Epub] CrossRef
The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Muthiah, Harriette G.C. Van Spall, Faiez Zannad, Javed Butler, Michael L. Volk, Marat Fudim JACC.2025; 86(20): 1861. CrossRef
Therapeutic potential of Akkermansia muciniphila in non-alcoholic fatty liver disease: a systematic review Parastoo Asghari, Maryam Ahmadi-Khorram, Alireza Hatami, Saeedeh Talebi, Asma Afshari BMC Gastroenterology.2025;[Epub] CrossRef
Macrophage Plg-RKT expression promotes diet-induced obesity and metabolic dysfunction-associated steatotic liver disease Lindsey A. Miles, Hongdong Bai, Sagarika Chakrabarty, Nagyung Baik, Yuqing Zhang, Robert J. Parmer, Fahumiya Samad Journal of Thrombosis and Haemostasis.2025;[Epub] CrossRef
A randomised double blind placebo-controlled clinical trial to evaluate the effects of Liv-Pro- a food supplement for Non-Alcoholic Fatty Liver Disease Anchala Ishani Kuruppu, Uditha Prabhath Liyanage, Aruni Chamika, Priyani Asoka Paranagama, Lankani Hettigoda Journal of Ayurveda and Integrative Medicine.2025; 16(6): 101196. CrossRef
Non-invasive liver fibrosis scores and mortality in a cohort of World Trade Center rescue/recovery workers Ankura Singh, Rachel Zeig-Owens, Nikolina Icitovic, David G Goldfarb, Charles B Hall, Jaeun Choi, Christopher R Dasaro, Victoria Garrity, Andrew C Todd, David J Prezant BMJ Open Gastroenterology.2025; 12(1): e001889. CrossRef
Attention-based graph neural network framework for non-invasive CAP score prediction in fatty liver disease via body modeling Ghasem Sadeghi Bajestani, Fatemeh Makhloughi, Ayoub Basham, Ebrahim Evazi, Mahdiyeh Razm Pour, Roohallah Alizadehsani, Farkhondeh Razmpour Physical and Engineering Sciences in Medicine.2025;[Epub] CrossRef
Depletion of FOXO4 promotes the development of nonalcoholic fatty liver disease by aggravating high-fat diet-induced liver injury by increasing SPP1 expression Li Huang, Guanghui Qian, Aimin Zhang, Lei Xu, Shuhui Wang, Yang Gao, Wenjie Li, Duane Wang, Miao Hou, Haitao Lv Arab Journal of Gastroenterology.2025;[Epub] CrossRef
Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice Jacqueline Wyss, Tina Raselli, Annika Wyss, Anja Telzerow, Gerhard Rogler, Niklas Krupka, Bahtiyar Yilmaz, Thomas S. B. Schmidt, Benjamin Misselwitz BMC Microbiology.2024;[Epub] CrossRef
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach Haijun Li, Yue Hu, Yuting Yang, Fengyan Xu, Zhongyi Sun, Jufang Huang, Kun Wang, Xiaoxin Chen European Journal of Pharmaceutical Sciences.2024; 199: 106808. CrossRef
Dietary Pattern’s Role in Hepatic Epigenetic and Dietary Recommendations for the Prevention of NAFLD Josefina I. Martín Barraza, David Bars-Cortina Nutrients.2024; 16(17): 2956. CrossRef
Assessment of melatonin’s therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats Davood Dorranipour, Fahimeh Pourjafari, Reza Malekpour-Afshar, Mohsen Basiri, Mehran Hosseini Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(5): 2971. CrossRef
Association of five diet scores with severe NAFLD incidence: A prospective study from UK Biobank Fanny Petermann‐Rocha, Fernanda Carrasco‐Marin, Jirapitcha Boonpor, Solange Parra‐Soto, Oliver Shannon, Fiona Malcomson, Nathan Phillips, Mahek Jain, Salil Deo, Katherine M. Livingstone, Sara E. Dingle, John C. Mathers, Ewan Forrest, Frederick K. Ho, Jill Diabetes, Obesity and Metabolism.2024; 26(3): 860. CrossRef
The effects of pomegranate consumption on liver function enzymes in adults: A systematic review and meta-analysis Hossein Bahari, Hossein Rafiei, Kian Goudarzi, Kosar Omidian, Omid Asbaghi, Kosar Sadat Hosseini Kolbadi, Moslem Naderian, Ali Hosseini Complementary Therapies in Medicine.2024; 80: 103008. CrossRef
BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice Beibei Xia, Rongfei Yu, Junxiong Liu, Dongmeng Liu, Shasha Li, Liu Yang, Nan Liu, Bosen Liang, Jiajing Zeng, Jinhua Wei, Guimiao Lin Toxicology Letters.2024; 391: 100. CrossRef
Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review Pervej Alom Barbhuiya, Saikat Sen, Manash Pratim Pathak Phytochemistry Reviews.2024; 23(4): 969. CrossRef
Multifocal fatty liver nodules mimicking a metastatic disease: A case report Huy Quang Duong, Shinya Kajiura, Tien Dinh Truong, Minh Tuan Ngo, Khai Xuan Nguyen, Hung Khanh Pham, Thang Ba Ta, Dung Tien Nguyen, Ryuji Hayashi Radiology Case Reports.2024; 19(3): 850. CrossRef
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina Life.2024; 14(1): 93. CrossRef
The Intersection of Genetic Factors, Aberrant Nutrient Metabolism and Oxidative Stress in the Progression of Cardiometabolic Disease Andrew J. Butcko, Ashley K. Putman, Emilio P. Mottillo Antioxidants.2024; 13(1): 87. CrossRef
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial Rong-Hong Hsieh, Yu-Ju Chien, Wen-Yi Lan, Yung-Kai Lin, Yung-Hsiang Lin, Chi-Fu Chiang, Ming-Ta Yang Current Developments in Nutrition.2024; 8(3): 102083. CrossRef
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD So Jung Kim, Jeongeun Hyun Molecules and Cells.2024; 47(2): 100010. CrossRef
Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up Hun Jee Choe, Joon Ho Moon, Won Kim, Bo Kyung Koo, Nam H. Cho Metabolism.2024; 153: 155800. CrossRef
Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, Jun-Hyuk Lee, Yu-Jin Kwon Digestive and Liver Disease.2024; 56(9): 1529. CrossRef
Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease Mihir Parikh, Broderick C. Hirst, Kimberley A. O’Hara, Thane G. Maddaford, J. Alejandro Austria, Aleksandra Stamenkovic, Liping Yu, Branislav Kura, Bhavana Garg, Thomas Netticadan, Spencer D. Proctor, Grant N. Pierce Nutrients.2024; 16(4): 466. CrossRef
The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease Jaejun Lee, Seungmyeon Choi, Seong-Hyun Cho, Hyun Yang, Pil-Soo Sung, Si-Hyun Bae Diagnostics.2024; 14(4): 393. CrossRef
Association between healthy beverage index and nonalcoholic fatty liver disease in the Ravansar noncommunicable disease cohort study Sepehr Sadafi, Ali Azizi, Shahab Rezaeian, Yahya Pasdar Scientific Reports.2024;[Epub] CrossRef
Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling Eunice X. Tan, Daniel Q. Huang, Natasha Tang Sook Yee, Zi Hui Wan, Sanjna N. Nerurkar, Justin Chua Ying Kai, Kang Shiong Goh, Cheng Han Ng, Mark Muthiah, Yu Zhou, Amanda Woodward, Michael H. Le, Yee Hui Yeo, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen Alimentary Pharmacology & Therapeutics.2024; 59(8): 984. CrossRef
Assessing the clinical and biochemical efficacy of alpha-lipoic acid in patients with non-alcoholic fatty liver disease: A randomized placebo-controlled clinical trial Mehrangiz Ebrahimi-Mameghani, Somayyeh Asghari, Fatemeh Naeini, Mahdiyeh Taghizadeh, Soudabeh Hamedi-Shahraki, Farshad Amirkhizi Journal of Functional Foods.2024; 114: 106050. CrossRef
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Mohamed El-Kassas, Abeer Awad, Mohamed Elbadry, Juan Pablo Arab Seminars in Liver Disease.2024; 44(01): 054. CrossRef
Perilipin 5 deletion protects against nonalcoholic fatty liver disease and hepatocellular carcinoma by modulating lipid metabolism and inflammatory responses Paola Berenice Mass-Sanchez, Marinela Krizanac, Paula Štancl, Marvin Leopold, Kathrin M. Engel, Eva Miriam Buhl, Josef van Helden, Nikolaus Gassler, Jürgen Schiller, Rosa Karlić, Diana Möckel, Twan Lammers, Steffen K. Meurer, Ralf Weiskirchen, Anastasia A Cell Death Discovery.2024;[Epub] CrossRef
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga Current Nutrition Reports.2024; 13(2): 152. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Dish: Human Precision-Cut Liver Slices as a Platform for Drug Screening and Interventions Mei Li, Frederik T. Larsen, Marius C. van den Heuvel, Konstanze Gier, Alan R. Gorter, Dorenda Oosterhuis, Johan Bijzet, Vincent E. de Meijer, Kim Ravnskjaer, Anika Nagelkerke, Peter Olinga Nutrients.2024; 16(5): 626. CrossRef
Advancing Endocrine Disruptors via In Vitro Evaluation: Recognizing the Significance of the Organization for Economic Co-Operation and Development and United States Environmental Protection Agency Guidelines, Embracing New Assessment Methods, and the Urge Sophie Fouyet, Marie-Caroline Ferger, Pascale Leproux, Patrice Rat, Mélody Dutot Toxics.2024; 12(3): 183. CrossRef
Therapeutic potential of Triphala and Gomutra in the management of non-alcoholic fatty liver disease: A review M S Deepa, V C Indulekha, Indu M Menon Journal of Drug Research in Ayurvedic Sciences.2024; 9(1): 8. CrossRef
Role of Vibration-Controlled Transient Elastography in the Evaluation and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease Elizabeth E. Williams, Raj Vuppalanchi Current Hepatology Reports.2024; 23(3): 355. CrossRef
4,4‐Diallyl curcumin bis(2,2‐hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine‐choline‐deficient diet and Western diet mouse models Li‐Chan Yang, Chih‐Chiang Wang, Der‐Yen Lee, Wen‐Chuan Lin, Sheng‐Chu Kuo, Shin‐Hun Juang, Min‐Tsang Hsieh Chemical Biology & Drug Design.2024;[Epub] CrossRef
A Cloud-Based System for Automated AI Image Analysis and Reporting Neil Chatterjee, Jeffrey Duda, James Gee, Ameena Elahi, Kristen Martin, Van Doan, Hannah Liu, Matthew Maclean, Daniel Rader, Arijitt Borthakur, Charles Kahn, Hersh Sagreiya, Walter Witschey Journal of Imaging Informatics in Medicine.2024; 38(1): 368. CrossRef
Adipocytokines as Predictors of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Development in Type 2 Diabetes Mellitus Patients Almir Fajkić, Rijad Jahić, Almira Hadžović-Džuvo, Orhan Lepara Cureus.2024;[Epub] CrossRef
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety Sushma Jadalannagari, Lorna Ewart Expert Opinion on Drug Metabolism & Toxicology.2024; 20(7): 607. CrossRef
Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe Maria Eleni Chondrogianni, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Harpal S. Randeva Frontiers in Endocrinology.2024;[Epub] CrossRef
Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease Saira Rafaqat, Sanja Gluscevic, Filiz Mercantepe, Sana Rafaqat, Aleksandra Klisic Metabolites.2024; 14(3): 153. CrossRef
Glucocorticoid resistance remodels liver lipids and prompts lipogenesis, eicosanoid, and inflammatory pathways Genesee J. Martinez, Zachary A. Kipp, Wang-Hsin Lee, Evelyn A. Bates, Andrew J. Morris, Joseph S. Marino, Terry D. Hinds Prostaglandins & Other Lipid Mediators.2024; 173: 106840. CrossRef
Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals Sarah L. Speck, Xiaochao Wei, Clay F. Semenkovich American Journal of Physiology-Cell Physiology.2024; 326(4): C1034. CrossRef
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel Cancers.2024; 16(6): 1214. CrossRef
Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials P. Ebrahimpour, M. Karamian, A. Sharifi Russian Journal of Gastroenterology, Hepatology, Coloproctology.2024; 34(1): 37. CrossRef
Effect of Gracilaria vermiculophylla Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats Maitane González-Arceo, Leixuri Aguirre, María Teresa Macarulla, Clàudia Gil-Pitarch, María Luz Martínez-Chantar, María P. Portillo, Saioa Gómez-Zorita Antioxidants.2024; 13(3): 369. CrossRef
Response to Article “Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients” [Letter] Putu Yuliandari, I Putu Bayu Mayura Journal of Multidisciplinary Healthcare.2024; Volume 17: 1413. CrossRef
Possibilities of a new assessment scale for prediction of chronic liver disease “CLivD” L. B. Lazebnik, S. V. Turkina Experimental and Clinical Gastroenterology.2024; (11): 62. CrossRef
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)? Kamila Kasprzak-Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk International Journal of Molecular Sciences.2024; 25(7): 3746. CrossRef
Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future Geltrude Mingrone, Harith Rajagopalan Diabetes Research and Clinical Practice.2024; 211: 111651. CrossRef
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, Maria Paraskevi Panoilia, Anna Daskou, Theodora Stratigou, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga Biomedicines.2024; 12(4): 826. CrossRef
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma Ohad Etzion, Avital Bareket-Samish, David Yardeni, Pnina Fishman Biomedicines.2024; 12(4): 848. CrossRef
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim Diabetes & Metabolism.2024; 50(3): 101534. CrossRef
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Ilaria Lenci, Leonardo Baiocchi, Francesco Luzza Medicina.2024; 60(4): 563. CrossRef
Gestational supplementation of Bifidobacterium, Lactobacillus, and Streptococcus thermophilus attenuates hepatic steatosis in offspring mice through promoting fatty acid β‐oxidation Hangjun Chen, Qiongmei Wu, Xingyi Chen, Xinxue Yu, Hanqing Zhao, Qiaoli Huang, Yurong Huang, Jinting Wang, Xueyi Huang, Jun Wei, Feng Wu, Xiaomin Xiao, Lijun Wang Journal of Food Science.2024; 89(5): 3064. CrossRef
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities Muhammed Mubarak World Journal of Gastrointestinal Pathophysiology.2024;[Epub] CrossRef
Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research E. V. Biryukova Meditsinskiy sovet = Medical Council.2024; (6): 72. CrossRef
Can Plasma Volume Determination in Cirrhosis Be Replaced by an Algorithm Using Body Weight and Hematocrit? Martine Prütz Nørskov, Thormod Mønsted, Nina Kimer, Morten Damgaard, Søren Møller Diagnostics.2024; 14(8): 835. CrossRef
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud Heliyon.2024; 10(9): e30387. CrossRef
Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials Mohamed Mahmoud Marey, Mohamed Belal, Abdelaziz A. Awad, Eslam Mohammed Rabea, Malak A. Hassan, Ahmed W. Abbas, Abdulqadir J. Nashwan Clinics and Research in Hepatology and Gastroenterology.2024; 48(6): 102357. CrossRef
A prospective observational cross-sectional study on the association of non-alcoholic fatty liver disease and insulin resistance in acute ischemic stroke in tertiary care hospital in Central India Dr. Jayanth Kumar, Dr Anuj Varma, Sourya Acharya, Sunil Kumar F1000Research.2024; 13: 434. CrossRef
Liver steatosis in patients with transfusion‐dependent thalassaemia Paolo Ricchi, Laura Pistoia, Vincenzo Positano, Anna Spasiano, Tommaso Casini, Maria Caterina Putti, Zelia Borsellino, Antonella Cossu, Giuseppe Messina, Petra Keilberg, Carmina Fatigati, Silvia Costantini, Stefania Renne, Giuseppe Peritore, Filippo Cadem British Journal of Haematology.2024; 204(6): 2458. CrossRef
Diagnostic performances of Fibrosis‐4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction‐associated steatotic liver disease in Asian primary care clinics Huiyul Park, Mimi Kim, Hye‐Lin Kim, Seon Cho, Eileen L. Yoon, Dae Won Jun Hepatology Research.2024; 54(11): 1027. CrossRef
Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion‐dependent thalassaemia Padmapani Padeniya, Anuja Premawardhena British Journal of Haematology.2024; 205(1): 28. CrossRef
Personalized medicine and nutrition in hepatology for preventing chronic liver disease in Mexico Arturo Panduro, Sonia Roman, Irene M. Mariscal-Martinez, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Claudia Ojeda-Granados, Omar Ramos-Lopez, Luis A. Torres-Reyes Frontiers in Nutrition.2024;[Epub] CrossRef
Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting Paula Luque-Linero, Luis Castilla-Guerra European Cardiology Review.2024;[Epub] CrossRef
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai‐Sun Wong, Thomas Reiberger, Thomas Karlas, Maja Thiele, Ana Carolina Cardoso, Oyekoya Taiwo Ayonrinde, Laurent Castera, Christoph Frank Dietrich, Hiroko Iijima, Dong Ho L Ultrasound in Medicine & Biology.2024; 50(8): 1071. CrossRef
Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a case–control study and serological comparison Zheng Lin, Yue-yi Shi, Lu-yan Yu, Chen-xi Ma, Si-yi Pan, Yuan Dou, Qiu-jun Zhou, Yi Cao Frontiers in Medicine.2024;[Epub] CrossRef
MASLD-mimicking microenvironment drives an aggressive phenotype and represses IDH2 expression in hepatocellular carcinoma Peyda Korhan, Ezgi Bağırsakçı, Yasemin Öztemur Islakoğlu, Gülhas Solmaz, Burcu Sarıkaya, Deniz Nart, Funda Yılmaz, Neşe Atabey Hepatoma Research.2024;[Epub] CrossRef
Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver Mrigya Babuta, Prashanth Thevkar Nagesh, Aditi Ashish Datta, Victoria Remotti, Yuan Zhuang, Jeeval Mehta, Francesca Lami, Yanbo Wang, Gyongyi Szabo Cells.2024; 13(11): 960. CrossRef
Prebiotic Treatment in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)—A Randomized Pilot Trial Naama Reshef, Uri Gophna, Leah Reshef, Fred Konikoff, Gila Gabay, Taiba Zornitzki, Hilla Knobler, Yaakov Maor Nutrients.2024; 16(11): 1571. CrossRef
Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva Current Obesity Reports.2024; 13(3): 510. CrossRef
Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Vinay Tergaonkar, Gautam Sethi, Lekshmi R. Nath Life Sciences.2024; 351: 122818. CrossRef
Emerging role of natural lipophagy modulators in metabolic dysfunction–associated steatotic liver disease Nahla E. El-Ashmawy, Eman G. Khedr, Ghada M. Al-Ashmawy, Asmaa A. Kamel Nutrition.2024; 126: 112517. CrossRef
Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions Ravi Adinarayan Somabattini, Sahla Sherin, Bhukya Siva, Neelanjan Chowdhury, Satheesh Kumar Nanjappan Life Sciences.2024; 351: 122806. CrossRef
Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis of randomized controlled trials Juan Wu, Xiaoyang Chen, Jun Qian, Guochun Li Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102397. CrossRef
Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea Yu-Jin Kwon, Ja-Eun Choi, Kyung-Won Hong, Ji-Won Lee Journal of Translational Medicine.2024;[Epub] CrossRef
Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort Bryan Adrian Priego-Parra, Sara Alejandra Reyes-Diaz, Héctor Ricardo Ordaz-Alvarez, Raúl Bernal-Reyes, Maria Eugenia Icaza-Chávez, Sophia Eugenia Martínez-Vázquez, Mercedes Amieva-Balmori, Héctor Vivanco-Cid, José Antonio Velarde-Ruiz Velasco, Jordi Graci Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102400. CrossRef
Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease Fatemeh Amani, Amirhossein Sahebkar, Seyed Hamid Aghaee-Bakhtiari, Mohammadreza Farzanehfar, Saeedeh Askarian, Reza Kazemi Oskuee Gene Reports.2024; 36: 101964. CrossRef
Bifidobacterium longumBL‐19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine Xiajun Zhang, Jingwen Xu, Xueyun Dong, Jiajun Tang, Yan Xie, Jie Yang, Limin Zou, Liang Wu, Jilong Fan Food Science & Nutrition.2024; 12(9): 6442. CrossRef
Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment Jingyi Ma, Dalton W. Staler, Ram I. Mahato Medicinal Chemistry Research.2024; 33(8): 1339. CrossRef
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis Muna Shakhshir, Sa'ed H Zyoud World Journal of Gastroenterology.2024; 30(24): 3106. CrossRef
The systemic inflammation response index as a risk factor for hepatic fibrosis and long-term mortality among individuals with metabolic dysfunction-associated steatotic liver disease Yufeng Yin, Weijia Zhu, Qingling Xu Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(8): 1922. CrossRef
Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study Sa'ed H Zyoud, Omar E Hegazi, Samer O Alalalmeh, Muna Shakhshir, Faris Abushamma, Shadi Khilfeh, Samah W Al-Jabi World Journal of Hepatology.2024; 16(6): 951. CrossRef
Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease Ammar L. Hussein, Dunia T. Nema, Gulboy A. Nasir Open Life Sciences.2024;[Epub] CrossRef
Effect of synbiotic supplementation on liver function, metabolic profile and gut microbiota in non-alcoholic fatty liver disease (NAFLD): A meta-analysis of randomized controlled trials Jihan Fadhilah, Hainun Zariyah, Adriyan Pramono, Hery Djagat Purnomo, Ahmad Syauqy, Diana Nur Afifah, Farhan Syafiq Fadhillah, Rachmania Anggita Purwanti Clinical Nutrition Open Science.2024; 56: 128. CrossRef
Experimental investigation for nonalcoholic fatty pancreas management using probiotics Marwa Matboli, Hiba S. Al-Amodi, Shaimaa Hamady, Marwa Ali, Marian MS Roushdy, Amany Helmy Hasanin, Yasmin M. Aboul-Ela, Reda Albadawy, Eman Gomaa, Hala F. M. Kamel, Hind A ELsawi, Laila M. Farid, Mariam B. Abouelkhair, Gena M Elmakromy, Nesma Mohamed Faw Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis Sa’ed H. Zyoud, Samer O. Alalalmeh, Omar E. Hegazi, Muna Shakhshir, Faris Abushamma, Samah W. Al-Jabi Gut Pathogens.2024;[Epub] CrossRef
Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship Hardika S Vegda, Bhavin Patel, Gaurav A Girdhar, Mohd. Shabankhan H Pathan, Rahnuma Ahmad, Mainul Haque, Susmita Sinha, Santosh Kumar Cureus.2024;[Epub] CrossRef
Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease Jennie Cao, Andy Shon, Luke Yoon, Aya Kamaya, Justin R. Tse European Radiology.2024; 34(12): 7622. CrossRef
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela, Maria Dalamaga Metabolites.2024; 14(7): 366. CrossRef
Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study Jingjing Sun, Chun Yan, Jing Wen, Fang Wang, Han Wu, Fang Xu BMC Gastroenterology.2024;[Epub] CrossRef
Linking physiology and demographics, non‐ocular pathology and pharmaceutical drug use to standard OCT measures of the inner retina: The PPP project Matt Trinh, Kelly O., Melanie La, Angelica Ly Ophthalmic and Physiological Optics.2024; 44(6): 1128. CrossRef
A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes Manvita Mareboina, Elen Deng, Ioannis Mouratidis, Nelson S. Yee, Nelly Pitteloud, Ilias Georgakopoulos-Soares, Dionysios V. Chartoumpekis Molecular Metabolism.2024; 87: 101987. CrossRef
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions Mohammad Beygi, Salma Ahi, Samaneh Zolghadri, Agata Stanek Nutrients.2024; 16(14): 2220. CrossRef
“Winning the peace” against obesity in recipients of liver transplant Kevin Pak, Sammy Saab Liver Transplantation.2024; 30(10): 979. CrossRef
Molybdenum’s Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review Jakub Piotr Adamus, Anna Ruszczyńska, Aleksandra Wyczałkowska-Tomasik Biomolecules.2024; 14(7): 869. CrossRef
Barriers to care linkage and educational impact on unnecessary MASLD referrals Jun-Hyuk Lee, Eileen Laurel Yoon, Ju Hyun Oh, Kyunam Kim, Sang Bong Ahn, Dae Won Jun Frontiers in Medicine.2024;[Epub] CrossRef
Effectiveness of mobile health intervention for non alcoholic fatty liver disease- A meta analysis of randomized controlled trials Rohit Kumar, Monika Rani, Ramsha, Vanesh Kumar, Sahil Kumar, Johar Abbas, Savanti, Monika Kumari, Aakash Kumar, Santosh, Muhammad Sohaib Asghar Clinics and Research in Hepatology and Gastroenterology.2024; 48(8): 102433. CrossRef
Effects of Propolis Consumption on Glycemic Indices and Liver Enzymes in Adults: A Grading of Recommendations Assessment, Development, and Valuation-assessed Systematic Review and Dose-Response Meta-analysis Shaghayegh Adeli, Mahsa Maroofi, Fatemeh Pourteymour Fard Tabrizi, Beitullah Alipour, Marzieh Heidari, Mahdi Vajdi, Mahdieh Abbasalizad-Farhangi Clinical Therapeutics.2024; 46(9): e6. CrossRef
Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes Merve Cebi, Yusuf Yilmaz Frontiers in Immunology.2024;[Epub] CrossRef
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma Byung-Kwan Jeong, Won-Il Choi, Wonsuk Choi, Jieun Moon, Won Hee Lee, Chan Choi, In Young Choi, Sang-Hyun Lee, Jung Kuk Kim, Young Seok Ju, Pilhan Kim, Young-Ah Moon, Jun Yong Park, Hail Kim Nature Communications.2024;[Epub] CrossRef
Mechanistic Insights into the Biological Effects and Antioxidant Activity of Walnut (Juglans regia L.) Ellagitannins: A Systematic Review Letiția Mateș, Roxana Banc, Flaviu Andrei Zaharie, Marius Emil Rusu, Daniela-Saveta Popa Antioxidants.2024; 13(8): 974. CrossRef
The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea Sung Won Chung, Min Kyung Park, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Heejoon Jang, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Xingshun Qi Canadian Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef
Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim Alimentary Pharmacology & Therapeutics.2024; 60(8): 1051. CrossRef
Therapeutic Effects of Semaglutide on Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial Ahmed I. Gad, Nevin F. Ibrahim, Noura Almadani, Rasha Mahfouz, Hanaa A. Nofal, Dina S. El-Rafey, Hossam Tharwat Ali, Amr T. EL-Hawary, Ayman M. E. M. Sadek Diseases.2024; 12(8): 186. CrossRef
Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant Lok Ka Lam, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Xianhua Mao, Ivan F N Hung, Wai Kay Seto, Man Fung Yuen, Ka Shing Cheung Journal of Gastroenterology and Hepatology.2024; 39(11): 2386. CrossRef
Protective effects of syringic acid in nonalcoholic fatty liver in rats through regulation of Nrf2/HO‐1 signaling pathway Simiao Zhang, Sheng Zheng, Ya Li, Juan Yang, Xiaozhou Mao, Tao Liu, Qiuxin Zhang, ZhiPeng Fu, Xing Zhu, Long Xu Journal of Biochemical and Molecular Toxicology.2024;[Epub] CrossRef
Intermittent fasting and the liver: Focus on the Ramadan model Mohamed H Emara, Hanan Soliman, Ebada M Said, Hassan Elbatae, Mostafa Elazab, Shady Elhefnawy, Tarik I Zaher, Ahmed Abdel-Razik, Mohamed Elnadry World Journal of Hepatology.2024; 16(8): 1070. CrossRef
Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis Jae Woong Jang, Emma Capaldi, Tracy Smith, Priyanka Verma, John Varga, Karen J. Ho Molecular Medicine.2024;[Epub] CrossRef
Shift work and non-alcoholic fatty liver disease in young, healthy workers Yesung Lee, Woncheol Lee Scientific Reports.2024;[Epub] CrossRef
Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis Fazal Hassan, Maria Farman, Kauser Aftab Khan, Muhammad Awais, Sohail Akhtar Scientific Reports.2024;[Epub] CrossRef
Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis Hareer Fatima, Hussain Sohail Rangwala, Muhammad Saqlain Mustafa, Muhammad Ashir Shafique, Syed Raza Abbas, Burhanuddin Sohail Rangwala Therapeutic Advances in Endocrinology and Metabolism.2024;[Epub] CrossRef
Protective effect of β-sitosterol against high-fructose diet-induced oxidative stress, and hepatorenal derangements in growing female sprague-dawley rats Nontobeko M. Gumede, Busisani W. Lembede, Pilani Nkomozepi, Richard L. Brooksbank, Kennedy H. Erlwanger, Eliton Chivandi Laboratory Animal Research.2024;[Epub] CrossRef
Vaccinium spp. Berries in the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Update of Preclinical and Clinical Research Ewelina Książek, Zuzanna Goluch, Marta Bochniak Nutrients.2024; 16(17): 2940. CrossRef
Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data from 201 Yangni Lu, Xianli Xu, Jianlin Wu, Lei Ji, Huiya Huang, Maowei Chen BMC Gastroenterology.2024;[Epub] CrossRef
Metabolic risk factors of colorectal cancer: Umbrella review Meseret Derbew Molla, Erin L. Symonds, Jean M. Winter, Ayal Debie, Molla M. Wassie Critical Reviews in Oncology/Hematology.2024; 204: 104502. CrossRef
Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis Narges Azizi, Hamed Naghibi, Madjid Shakiba, Mina Morsali, Diana Zarei, Hedayat Abbastabar, Hossein Ghanaati European Radiology.2024; 35(4): 1794. CrossRef
Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches Shradha P Kakde, Maham Mushtaq, Maryyam Liaqat, Husnain Ali, Muhammad Muaz Mushtaq, Muhammad Asad Sarwer, Sami Ullah, Muhammad Wali Hassan, Asma Khalid, Syed Faqeer Hussain Bokhari Cureus.2024;[Epub] CrossRef
Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy Yalçın Burak Kara, Yahya Ozel Cureus.2024;[Epub] CrossRef
Key challenges of post-liver transplant weight management Maja Cigrovski Berkovic, Vibor Šeša, Ivan Balen, Quirino Lai, Hrvoje Silovski, Anna Mrzljak World Journal of Transplantation.2024;[Epub] CrossRef
Characterizing Unique Clinical and Virological Profiles in Concurrent Chronic Hepatitis B and Metabolic Dysfunction-Associated Liver Disease: Insights from a Population-Based Cohort Study Fadi Abu Baker, Abdel-Rauf Zeina, Randa Taher, Saif Abu Mouch, Ariel Israel Journal of Clinical Medicine.2024; 13(18): 5608. CrossRef
Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study Yewan Park, Jooyi Jung, Seungbong Han, Gi‐Ae Kim Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1599. CrossRef
The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction‐associated steatotic liver disease and metabolic dysfunction and alcohol‐associated liver disease Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, Takanori Kashihara, Ryo Shinomiya, Takanori Miyake, Tomoyuki Kawaguchi, Reiko Yokoyama, Kaizo Kagemoto, Yoshifumi Kida, Yasuyuki Okada, Tetsu Tomonari, Yutaka Kawano, Yasushi Sato, Masahiko Nakasono, Tetsuj Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1587. CrossRef
Polymorphism of PNPLA3 and TM6SF2 genes in patients with nonalcoholic fatty liver disease resident at Gomel region N. S. Branovitskaya Health and Ecology Issues.2024; 21(3): 45. CrossRef
Impact of Non-Alcoholic Fatty Liver Disease on Sepsis Inpatient Outcomes: A Nationwide Sample Analysis (2000–2019) Xiuhong Lyu, Bolun Liu, Yiting Li, Yichen Wang, John Miskovsky, Melissa Gaitanis, Kittichai Promrat, Wen-Chih Wu Journal of Clinical Medicine.2024; 13(19): 5737. CrossRef
The nonlinear connection between relative fat mass and non-alcoholic fatty liver disease in the Japanese population: an analysis based on data from a cross-sectional study Changchun Cao, Meiling Huang, Yong Han, Xiaohua Zhang, Haofei Hu, Yulong Wang Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
Polycystic ovary syndrome: a multisystemic approach to metabolic dysfunctions – review Elena Popa, Ana-Aurelia Chiş-Şerban, Mihaela Poroch, Andrei-Emilian Popa, Raluca-Ioana Avram, Adorata-Elena Coman Medic.ro.2024; 4(160): 49. CrossRef
Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis Young Eun Chon, Young-Joo Jin, Jihyun An, Hee Yeon Kim, Miyoung Choi, Dae Won Jun, Mi Na Kim, Ji Won Han, Han Ah Lee, Jung Hwan Yu, Seung Up Kim Clinical and Molecular Hepatology.2024; 30(Suppl): S117. CrossRef
Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients Jin Cui, Lianbang Wang, Armin Ghavamian, Xuemei Li, Gongzheng Wang, Tao Wang, Min Huang, Qi Ru, Xinya Zhao BMC Gastroenterology.2024;[Epub] CrossRef
Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification Min Kyu Kang, Jeong Eun Song, Rohit Loomba, Soo Young Park, Won Young Tak, Young Oh Kweon, Yu Rim Lee, Jung Gil Park Scientific Reports.2024;[Epub] CrossRef
Construction and comparative analysis of an early screening prediction model for fatty liver in elderly patients based on machine learning Xiaolei Cai, Qi Sun, Cen Qiu, Zhenyu Xie, Jiahao He, Mengting Tu, Xinran Zhang, Yang Liu, Zhaojun Tan, Yutong Xie, Xixuan He, Yujing Ren, Chunhong Xue, Siqi Wang, Linrong Yuan, Miao Yu, Xuelin Cheng, Xiaopan Li, Sunfang Jiang, Huirong Zhu Progress in Medical Devices.2024;[Epub] CrossRef
Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians Margeyi Mehta, Jigish Shah, Urvish Joshi Cureus.2024;[Epub] CrossRef
Targeting histamine in metabolic syndrome: Insights and therapeutic potential Yiting Wang, Fude Fang, Xiaojun Liu Life Sciences.2024; 358: 123172. CrossRef
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation Chin Long Poo, Mei Siu Lau, Nur Liana Md Nasir, Nik Aina Syazana Nik Zainuddin, Mohd Rahimi Ashraf Abd Rahman, Siti Khadijah Mustapha Kamal, Norizah Awang, Hussin Muhammad Current Issues in Molecular Biology.2024; 46(10): 11460. CrossRef
Beyond the Heart: The Predictive Role of Coronary Artery Calcium Scoring in Non-Cardiovascular Disease Risk Stratification Viviana Cortiana, Hetvee Vaghela, Rahul Bakhle, Tony Santhosh, Oroshay Kaiwan, Aalia Tausif, Ashish Goel, Mohammed K. Suhail, Neil Patel, Omar Akram, Nirja Kaka, Yashendra Sethi, Arsalan Moinuddin Diagnostics.2024; 14(21): 2349. CrossRef
Gut Microbiota Dysbiosis in the Pathogenesis of Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD) Gh Jeelani Mir, Nissar Ul Ashraf The International Journal of Gastroenterology and Hepatology Diseases.2024;[Epub] CrossRef
Amino acid is a major carbon source for hepatic lipogenesis Yilie Liao, Qishan Chen, Lei Liu, Haipeng Huang, Jingyun Sun, Xiaojie Bai, Chenchen Jin, Honghao Li, Fangfang Sun, Xia Xiao, Yahong Zhang, Jia Li, Weiping Han, Suneng Fu Cell Metabolism.2024; 36(11): 2437. CrossRef
“Regulation of adipose-derived fatty acid flux to the liver”-Impact on metabolic dysfunction-associated steatotic liver disease Erika Folestad, Annelie Falkevall Current Opinion in Endocrine and Metabolic Research.2024; 37: 100559. CrossRef
Vitamin E and Non-alcoholic Fatty Liver Disease: Investigating the Evidence Through a Systematic Review Mahlet Abera, Suchith B Suresh, Aparna Malireddi, Sruthi Boddeti, Khutaija Noor, Mehwish Ansar, Iana Malasevskaia Cureus.2024;[Epub] CrossRef
Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against So Jung Kim, Jeongeun Hyun Clinical and Molecular Hepatology.2024; 30(4): 709. CrossRef
Machine-Learning Application for Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease Using Laboratory and Body Composition Indicators Fatemeh Masaebi, Mehdi Azizmohammad Looha, Morteza Mohammadzadeh, Vida Pahlevani, Mojtaba Farjam, Farid Zayeri, Reza Homayounfar Archives of Iranian Medicine.2024; 27(10): 551. CrossRef
Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice Gi Cheol Park, Soo-Young Bang, Ji Min Kim, Sung-Chan Shin, Yong-il Cheon, Kwang Min Kim, Hanaro Park, Eui-Suk Sung, Minhyung Lee, Jin-Choon Lee, Byung-Joo Lee Antioxidants.2024; 13(11): 1336. CrossRef
The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease Na Li, Liyuan Hao, Shenghao Li, Jiali Deng, Fei Yu, Junli Zhang, Aiyu Nie, Xiaoyu Hu Journal of Inflammation Research.2024; Volume 17: 8061. CrossRef
Longer sitting times and bulk amounts of rice intake are associated with the increased risks of metabolic dysfunction-associated fatty liver diseases (MAFLD): A case-control study Shahinul Alam, Mahbuba Kawser, Saif Uddin Nisar Ahmed, Md Mahabubul Alam, Md Saiful Islam, Shayla Nasrin Clinical Nutrition Open Science.2024; 58: 275. CrossRef
Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways Kenneth Maiese World Journal of Cardiology.2024; 16(11): 632. CrossRef
The Interplay of Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Call for Integrated Management Carmine Zoccali, Francesca Mallamaci American Journal of Nephrology.2024; : 1. CrossRef
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders Pranali A. Jadhav, Asha B. Thomas, Vinay M. Chopada, Prajay V. Bokaria, Shivam B. Deokate, Pankaj S. Chougule, Pruthviraj N. Chavan, Sohan S. Chitlange Egyptian Liver Journal.2024;[Epub] CrossRef
Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Julia Markowska, Kamila Kasprzak-Drozd, Przemysław Niziński, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek, Tomasz Oniszczuk, Anna Oniszczuk Molecules.2024; 29(22): 5245. CrossRef
Metabolic-associated steatotic liver disease and hepatocellular carcinoma Giovanni Catalano, Odysseas P. Chatzipanagiotou, Jun Kawashima, Timothy M. Pawlik Expert Opinion on Pharmacotherapy.2024; 25(17): 2283. CrossRef
Association of dietary inflammatory index with sarcopenia in patients with Metabolic dysfunction-associated fatty liver disease: a cross-sectional study Xianyao Wang, Rongjie Shi, Ying Zi, Jun Long Frontiers in Nutrition.2024;[Epub] CrossRef
Inhibition of the miR-1914-5p increases the oxidative metabolism in cellular model of steatosis by modulating the Sirt1-PGC-1α pathway and systemic cellular activity Thais Porto-Barbosa, Letícia Ferreira Ramos, Camila Cristiane Pansa, Letícia Ramos Molica, Osmar Malaspina, Karen C. M. Moraes, Prasanth Puthanveetil PLOS ONE.2024; 19(11): e0313185. CrossRef
Advances in liver engineering with cell, scaffold, and vascularization Chunyan Liu, Yulian Wang, Xuqian Zhou, Lei Dong EngMedicine.2024; 1(3): 100041. CrossRef
Establishment and characterization of mouse metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma organoids Sumin Kim, Nahyun Jeong, Jeayeon Park, Hyojin Noh, Ja Oh Lee, Su Jong Yu, Ja-Lok Ku Scientific Reports.2024;[Epub] CrossRef
Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu Frontiers in Pharmacology.2024;[Epub] CrossRef
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice Vincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro, Adriano De Santis, Giovanni Di Minno, Luca Fabris, Fabio Marra, Filomena Morisco, Flora Peyvandi, Maurizio Pompili, Cristina Santoro, Ezio Zanon, Giancarlo Castaman Blood Advances.2024; 8(22): 5725. CrossRef
Jolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway Hye-Rin Noh, Guoyan Sui, Jin Woo Lee, Feng Wang, Jeong-Su Park, Yuanqiang Ma, Hwan Ma, Ji-Won Jeong, Dong-Su Shin, Xuefeng Wu, Bang-Yeon Hwang, Yoon Seok Roh Biomolecules & Therapeutics.2024; 32(6): 793. CrossRef
The correlation between metabolic dysfunction-associated steatotic liver disease (MASLD) grades and hemodynamic alterations of the portal, hepatic, and splenic vein and spleen size Soheila Borji, Hadi Sabat Sani, Saharnaz Ghorbani, Mohammad Soltani, Vahid Mohammadi, Reza Elahi Journal of Ultrasound.2024; 28(2): 339. CrossRef
High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction Seong-Uk Baek, Jin-Ha Yoon Biomolecules.2024; 14(11): 1468. CrossRef
Revolutionizing the understanding of liver disease: Metabolism, function and future Arnulfo E Morales-Galicia, Mariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Nahum Méndez-Sánchez World Journal of Hepatology.2024; 16(12): 1365. CrossRef
A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis—A Pilot Study Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, Konstantinos Arvanitakis, Eleni Theocharidou, Georgios Germanidis, Helen Gika International Journal of Molecular Sciences.2024; 25(23): 13067. CrossRef
Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis Shoham Dabbah, Itamar Mishani, Yana Davidov, Ziv Ben Ari Digestion.2024; 106(3): 189. CrossRef
MRI-PDFF Assessment of Intrahepatic Fat Changes Post-Bariatric Surgery: A Systematic Literature Review Danut Dejeu, Paula Dejeu, Anita Muresan, Paula Bradea, Viorel Dejeu Medicina.2024; 60(12): 2003. CrossRef
Body mass index and waist-to-height ratio effect on mortality in non-alcoholic fatty liver: revisiting the obesity paradox Hao Jiang, Mingkai Li, Hongsheng Yu, Yinan Huang, Bilan Yang, Bin Wu, Yidong Yang Frontiers in Endocrinology.2024;[Epub] CrossRef
Impact of Post-Thaw Enrichment of Primary Human Hepatocytes on Steatosis, Inflammation, and Fibrosis in the TruVivo® System Justin J. Odanga, Sharon M. Anderson, Sharon C. Presnell, Edward L. LeCluyse, Jingsong Chen, Jessica R. Weaver Pharmaceuticals.2024; 17(12): 1624. CrossRef
Oral Pathogens’ Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer’s, Diabetes, and Other Systemic Diseases: A Public Health Crisis—A Comprehensive Review Peter E. Murray, Jonathan A. Coffman, Franklin Garcia-Godoy Pathogens.2024; 13(12): 1084. CrossRef
A Survey Assessing Nonalcoholic Fatty Liver Disease Knowledge Among Hepatologists and Non‐Hepatologists in China Laura Colombo JGH Open.2024;[Epub] CrossRef
Metabolomics at the cutting edge of risk prediction of MASLD En Ying Tan, Mark D. Muthiah, Arun J. Sanyal Cell Reports Medicine.2024; 5(12): 101853. CrossRef
Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases Isis Trujillo-Gonzalez, Paul G. Thomes, Isin Tuna Sakallioglu, Kusum K. Kharbanda Frontiers in Pharmacology.2024;[Epub] CrossRef
Non-alcoholic fatty liver disease among people living with HIV on long-term antiretroviral therapy in Indonesia: Prevalence and related factors Hikmat Pramukti, Evy Yunihastuti, Rino A Gani, Ikhwan Rinaldi, Irsan Hasan, Suzy Maria SAGE Open Medicine.2024;[Epub] CrossRef
High-fat diet mouse model receiving L-glucose supplementations propagates liver injury Johnny Amer, Athar Amleh, Ahmad Salhab, Yuval Kolodny, Shira Yochelis, Baker Saffouri, Yossi Paltiel, Rifaat Safadi Frontiers in Nutrition.2024;[Epub] CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators Danusia Onișor, Andrada Larisa Roiban, Simona Cernea Medicina.2024; 60(12): 2091. CrossRef
Assessment of Non-alcoholic Fatty Liver Disease and Level of Risk of Fibrosis in Diabetic and Non-diabetic Individuals Miah Wahiduzzaman, Noor-E- Ferdous, K. M. Mozibul Haque, A. K. M. Shamsul Kabir, Md. Adib Siddiki, Md. Tanim Hossain , Qazi Ashrafur Rahman , Al Istiak Ur Rahman , A. H. M. Golam Kibria Cureus.2024;[Epub] CrossRef
Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It? Catherine Stankevicius, Rachel H. Davis, Dep Huynh, Martine Hatzi, Stephanie Morgillo, Alice S. Day Journal of Digestive Diseases.2024; 25(11-12): 645. CrossRef
Non-alcoholic fatty liver disease and chronic kidney disease S. V. Turkina, I. A. Tyshchenko, M. N. Titarenko Experimental and Clinical Gastroenterology.2024; (10): 49. CrossRef
Editorial: clinical outcomes in lean NAFLD—the devil is in the details Eunice X. X. Tan, Mark Dhinesh Muthiah, Cheng Han Ng, Daniel Q. Huang Alimentary Pharmacology & Therapeutics.2023; 57(9): 1040. CrossRef
Noninvasive Assessment of Liver Fibrosis in NAFLD Arun J. Sanyal, Laurent Castera, Vincent Wai-Sun Wong Clinical Gastroenterology and Hepatology.2023; 21(8): 2026. CrossRef
Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome Hafeja Akhter Hima, Md Abdul Hannan Miah, Nipa Rani Ghosh, Sazia Sultana, Tanjina Akter, Fatema Tuz Zahura Aalpona, A. B. M. Kamrul-Hasan Bangladesh Journal of Endocrinology and Metabolism.2023; 2(2): 80. CrossRef
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD Ana Petrovic, Dunja Igrec, Karla Rozac, Kristina Bojanic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Mihaljevic, Renata Sikora, Robert Smolic, Marija Glasnovic, George Y. Wu, Martina Smolic Current Issues in Molecular Biology.2023; 45(6): 4544. CrossRef
Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018 Wenli Cheng, Min Li, Luyun Zhang, Cheng Zhou, Xinyu Zhang, Chenyu Zhu, Luyi Tan, Hui Lin, Wenjuan Zhang, Wenji Zhang Annals of Medicine.2023;[Epub] CrossRef
Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose Soo-Mi Kweon, Jose Irimia-Dominguez, Gayeoun Kim, Patrick T. Fueger, Kinji Asahina, Keith K. Lai, Daniela S. Allende, Quincy R. Lai, Chih-Hong Lou, Walter M. Tsark, Ju Dong Yang, Dominic S. Ng, Ju-Seog Lee, Patrick Tso, Wendong Huang, Keane K. Y. Lai American Journal of Physiology-Gastrointestinal and Liver Physiology.2023; 325(2): G147. CrossRef
Synergistic Preventive Effect of Aerobic and Resistance Exercises on Nonalcoholic Fatty Liver Disease Ju-Yeon Cho, Won Sohn Gut and Liver.2023; 17(4): 487. CrossRef
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel World Journal of Gastroenterology.2023; 29(32): 4831. CrossRef
Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target Yuan Yao, Yunfeng Shen Open Life Sciences.2023;[Epub] CrossRef
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Syn, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Vincent Wai‐Sun Wong, Christos S. Mantzoro Alimentary Pharmacology & Therapeutics.2023; 58(10): 1062. CrossRef
Ameliorative Effects of Anthocyanin Metabolites on Western Diet-Induced NAFLD by Modulating Co-Occurrence Networks of Gut Microbiome Hironobu Nakano, Kozue Sakao, Koji Wada, De-Xing Hou Microorganisms.2023; 11(10): 2408. CrossRef
Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease Ramona Cadar, Corina Lupascu Ursulescu, Alin Mihai Vasilescu, Ana Maria Trofin, Mihai Zabara, Delia Rusu-Andriesi, Bogdan Ciuntu, Cristina Muzica, Cristian Dumitru Lupascu Life.2023; 13(10): 1987. CrossRef
Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease Niketa Sharma, Swarupa Chakole, Bhushan Wandile Cureus.2023;[Epub] CrossRef
Unveiling the role of gut dysbiosis in non-alcoholic fatty liver disease Pranali A. Jadhav, Asha B. Thomas, Rabindra K. Nanda, Sohan S. Chitlange European Journal of Gastroenterology & Hepatology.2023; 35(12): 1324. CrossRef
Decellularization Techniques for Tissue Engineering: Towards Replicating Native Extracellular Matrix Architecture in Liver Regeneration Ishita Allu, Ajay Kumar Sahi, Meghana Koppadi, Shravanya Gundu, Alina Sionkowska Journal of Functional Biomaterials.2023; 14(10): 518. CrossRef
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases Yankai Wen, Lichun Ma, Cynthia Ju eGastroenterology.2023; 1(2): e100020. CrossRef
Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics Huan Yang, Yunshan Li, Weihong Xu, Wenjuan Liu, Ying Xie Frontiers in Medicine.2023;[Epub] CrossRef
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca Diagnostics.2023; 13(21): 3316. CrossRef
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds Stephanie Venn-Watson, Nicholas J. Schork Nutrients.2023; 15(21): 4607. CrossRef
Association or causation: still more questions than answers in early-onset gastrointestinal cancers E. Fontana, I. Ben-Aharon ESMO Gastrointestinal Oncology.2023; 1: 40. CrossRef
The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression Valerio Caputo, Giovanni Tarantino, Silvano Santini, Giovanna Fracassi, Clara Balsano Nutrients.2023; 15(22): 4757. CrossRef
Unraveling the Connection between Fatty Liver Severity with Gender, Lifestyle, and Health Risks among Workers Feng-Cheng Tang, Ren-Hau Li, Jui-Hua Huang Nutrients.2023; 15(22): 4765. CrossRef
Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Satoru Saito, Atsushi Nakajima Gut and Liver.2023; 17(6): 843. CrossRef
Editorial: Interactions between NAFLD and cardiac conduction, structure and function: recent advances and treatments Christiano Argano Frontiers in Endocrinology.2023;[Epub] CrossRef
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease Cheng-Wei Yu, Chia-Hung Chen, Yung-Chi Cheng, Wen-Che Hsieh, Tzu-Ju Hsu, Fuu-Jen Tsai, Chao-Yu Hsu European Journal of Medical Research.2023;[Epub] CrossRef
Trends of nonalcoholic fatty liver research in Southeast Asia from 2004 to 2022: A bibliometric analysis Vivien Joyce D. Josol, Paul Benedic U. Salvador, Linnaeus Louisse A. Cruz, Eric David B. Ornos, Ourlad Alzeus G. Tantengco Obesity Medicine.2023; : 100527. CrossRef
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity Ilaria Barchetta, Flavia Agata Cimini, Federica Sentinelli, Caterina Chiappetta, Claudio Di Cristofano, Gianfranco Silecchia, Frida Leonetti, Marco Giorgio Baroni, Maria Gisella Cavallo International Journal of Molecular Sciences.2023; 24(24): 17174. CrossRef
A Comprehensive Review on Non-Alcoholic Fatty Liver Disease Prerna Sahu, Pratyaksh Chhabra, Ashok M Mehendale Cureus.2023;[Epub] CrossRef
Developmental Programming: Impact of Prenatal Exposure to Bisphenol A on Senescence and Circadian Mediators in the Liver of Sheep Giuliana Motta, Soundara Viveka Thangaraj, Vasantha Padmanabhan Toxics.2023; 12(1): 15. CrossRef
Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, Adithya Suresh, Kaiser Xuan Ming Koh, Wen Hui Lim, Jingxuan Quek, Ansel Tang, Caitlyn Tan, Benjamin Nah, Eunice Tan, Taisei Keitoku, Mark D. Muthiah, Nicholas Syn, Cheng Han Ng, Beom Kyung Kim, Nobuharu Tamaki, Cyrus Su Hui Ho, Rohit Loomba, Daniel Q. Huang
Clin Mol Hepatol 2022;28(4):864-875. Published online July 25, 2022
Background/Aims Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish the prevalence of depression and anxiety in patients with HCC.
Methods MEDLINE and Embase were searched and original articles reporting prevalence of anxiety or depression in patients with HCC were included. A generalized linear mixed model with Clopper-Pearson intervals was used to obtain the pooled prevalence of depression and anxiety in patients with HCC. Risk factors were analyzed via a fractional-logistic regression model.
Results Seventeen articles involving 64,247 patients with HCC were included. The pooled prevalence of depression and anxiety in patients with HCC was 24.04% (95% confidence interval [CI], 13.99–38.11%) and 22.20% (95% CI, 10.07–42.09%) respectively. Subgroup analysis determined that the prevalence of depression was lowest in studies where depression was diagnosed via clinician-administered scales (16.07%;95% CI, 4.42–44.20%) and highest in self-reported scales (30.03%; 95% CI, 17.19–47.01%). Depression in patients with HCC was lowest in the Americas (16.44%; 95% CI, 6.37–36.27%) and highest in South-East Asia (66.67%; 95% CI, 56.68–75.35%). Alcohol consumption, cirrhosis, and college education significantly increased risk of depression in patients with HCC.
Conclusions One in four patients with HCC have depression, while one in five have anxiety. Further studies are required to validate these findings, as seen from the wide CIs in certain subgroup analyses. Screening strategies for depression and anxiety should also be developed for patients with HCC.
Citations
Citations to this article as recorded by
Symptom Cluster Trajectories Among Patients With Hepatocellular Carcinoma After Partial Hepatectomy: A Longitudinal Study Yanxiu Cai, Jing Li, Liuna Bi, Linlin Wang, Jing Han Journal of Clinical Nursing.2025; 34(10): 4166. CrossRef
Is Health Status in Patients With Chronic Disorders of the Gastrointestinal System Disease‐Specific? Results From an Integral Approach Anja H. W. M. Lemlijn‐Slenter, Luuk P. van Iperen, Karolina A. P. Wijnands, Nico Wolter, Angelique E. de Rijk, Ad A. M. Masclee Neurogastroenterology & Motility.2025;[Epub] CrossRef
Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy Alejandra Calvo-Schimmel, Marilyn J. Hammer, Yvette P. Conley, Steven M. Paul, Bruce A. Cooper, Joosun Shin, Carolyn Harris, Lisa Morse, Jon D. Levine, Christine Miaskowski Seminars in Oncology Nursing.2025; 41(2): 151809. CrossRef
Paeoniflorin inhibits chronic restraint stress-induced progression of hepatocellular carcinoma through suppressing norepinephrine-induced activation of hepatic stellate cells via SRC/AKT/ERK pathways Yujun Luo, Wanfu Lin, Shuang Xiang, Yuanrong Shi, Meihuan Fu, Xiaofeng Zhai, Changquan Ling, Binbin Cheng Journal of Ethnopharmacology.2025; 344: 119517. CrossRef
Global research trends on gastrointestinal cancer and mental health (2004–2024): a bibliographic study Wenjin Han, Tianmeng Wang, Zhiqiang He, Caihua Wang, Zhaozhao Hui, Shuangyan Lei, Nan Hao, Ning Li, Xiaoqin Wang Frontiers in Medicine.2025;[Epub] CrossRef
Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: an umbrella review of systematic reviews and meta-analyses Addisu Getie, Manay Ayalneh, Melaku Bimerew BMC Psychiatry.2025;[Epub] CrossRef
Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide Vishnu Nagalapuram, Niveditha Popuri, Ryan D. Nipp, Susanna V. Ulahannan, Kelsey S. Lau-Min JCO Oncology Practice.2025; 21(9): 1247. CrossRef
Depressive symptoms and immune depletion in Chinese patients with advanced hepatocellular carcinoma: a multicentre study on their correlation Yan Zhang, Wei Zhou, Zhiping Ma, Zutao Chen, Naiping Li, Xiaomin Zhu, Yunhai Yao General Psychiatry.2025; 38(2): e101822. CrossRef
Factors influencing anxiety and depression in advanced hepatocellular carcinoma patients and their impact on quality of life Maher Hendi, Bin Zhang, Jie-Min Lv, Xiu-Jun Cai World Journal of Psychiatry.2025;[Epub] CrossRef
Sini Powder Alleviates Stress Response and Suppresses Hepatocellular Carcinoma Development by Restoring Gut Microbiota Si Mei, Zhe Deng, Fan-ying Meng, Qian-qian Guo, He-yun Tao, Lin Zhang, Chang Xi, Qing Zhou, Xue-fei Tian Chinese Journal of Integrative Medicine.2025; 31(9): 802. CrossRef
Nervous system in hepatocellular carcinoma: Correlation, mechanisms, therapeutic implications, and future perspectives Wenxuan Li, Jinghao Zhang, Yueqiu Gao, Xiaoni Kong, Xuehua Sun Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2025; 1880(3): 189345. CrossRef
Molecular mechanisms and clinical value of the correlation between depression and cancer Yuxiao Chen, Yafei Lu, Siyi Chen, Pengyi Liu, Junzhe He, Lingxi Jiang, Jun Zhang Medical Oncology.2025;[Epub] CrossRef
Pyrimidinetrione benzodioxol ameliorates MAFLD-induced liver tumorigenesis and mood disorders in mice Fang-Yu Hsu, Wan-Chun Chiu, Fat-Moon Suk, Chun-Ya Lee, Ming-Hua Hsu, Yi-Jen Liao npj Gut and Liver.2025;[Epub] CrossRef
Educational, financial, logistical, emotional, and social needs among patients with hepatocellular carcinoma Debbiesiu L. Lee, Sophia Hon, Daniela Prieto Bello, Lucia Fernandez, Patricia D. Jones Hepatology Communications.2025;[Epub] CrossRef
Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway Yongfei He, Qiang Tao, Shutian Mo, Meifeng Chen, Jicai Wang, Hang Zhai, Shengjie Hong, Qiang Gao, Guangquan Zhang, Chuangye Han, Xianjie Shi Frontiers in Oncology.2025;[Epub] CrossRef
The impact of graded nursing interventions based on quantitative risk assessment on psychological stress responses in patients undergoing resection for primary liver cancer Li Zhang, Xiaochao Ren, Luping Xu, Siming Zheng, Qinhong Xu BMC Nursing.2025;[Epub] CrossRef
The Factors Influencing Quality of Life Among Patients With Hepatobiliary and Pancreatic Cancers Sunhee Hwang, Jieun Lee, Junglyun Kim Western Journal of Nursing Research.2025; 47(11): 1025. CrossRef
Psychisches Befinden bei PatientInnen mit Leberzellkarzinom Karen Rischmüller, Veronika Kakouz, Martin Philipp, Theresia Blattmann, Georg Lamprecht, Susanne Singer Die Onkologie.2025; 31(12): 1202. CrossRef
The prevalence of anxiety and depression in cancer around the world: An overview of systematic reviews evaluating 128 meta-analyses Javier Martinez-Calderon, Cristina García-Muñoz, Alberto Marcos Heredia-Rizo, Francisco Javier Cano-García Journal of Affective Disorders.2024; 351: 701. CrossRef
Psychiatric disorders in patients with hepatocellular carcinoma: A large US cohort of commercially insured individuals Mausam J. Patel, Alex Jones, Yue Jiang, Prajwal Gowda, Lisa B. VanWagner, Thomas G. Cotter, Karim Seif El Dahan, Jeremy Louissaint, Madhukar Patel, Nicole E. Rich, Amit G. Singal, Sarah R. Lieber Alimentary Pharmacology & Therapeutics.2024; 60(4): 469. CrossRef
The relationship between social determinants of health and neurocognitive and mood-related symptoms in the primary brain tumor population: A systematic review Macy L Stockdill, Amanda King, Morgan Johnson, Zuena Karim, Diane Cooper, Terri S Armstrong Neuro-Oncology Practice.2024; 11(3): 226. CrossRef
Social short video platform assisted care for adverse psychological symptoms in cancer patients: A mixed‐methods study Shen Li, Xia Liu, Xia Wang, Yilin Wang, Xuelei Ma MedComm – Future Medicine.2024;[Epub] CrossRef
Chronic stress influences the macrophage M1-M2 polarization balance through β-adrenergic signaling in hepatoma mice Juanjuan Yang, Wei Wei, Shuqun Zhang, Wei Jiang International Immunopharmacology.2024; 138: 112568. CrossRef
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians Massimo Iavarone, Lorenzo Canova, Eleonora Alimenti, Alessio Aghemo, Diego Taveggia, Gino Gobber, Giuseppe Cabibbo, Simone Veronese, Vincenza Calvaruso, Luciano Orsi, Paolo Caraceni, Pietro Lampertico Palliative Medicine.2024; 38(9): 1033. CrossRef
Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy Feng-Juan Zhao, Rong-Rui Huo, Fan-Rong Li, Xue-Mei You Supportive Care in Cancer.2024;[Epub] CrossRef
Systemic Connective Tissue Disease and Neuromyelitis Optica Spectrum Disorder Coexistence: A Systematic Review and Meta-Analysis Jessica Elisabetta Esposito, Giovanni Annoni, Milena D’Amato, Alessandra Graziosi, Francesca Troilo, Annalisa Di Risio, Gilda Angelini, Caterina Castiglione, Pierluigi Tocco, Paola Volpe, Giancarlo Di Iorio, Giustino Parruti, Ennio Polilli Journal of Integrative Neuroscience.2024;[Epub] CrossRef
Barriers to palliative care in hepatocellular carcinoma: A review of the literature Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry Journal of Gastroenterology and Hepatology.2023; 38(7): 1047. CrossRef
Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng Clinical and Molecular Hepatology.2023; 29(3): 821. CrossRef
An offline to online cognitive behavioral stress management caring program effectively improves psychological pressure, spiritual well-being, and quality of life in postoperative hepatocellular carcinoma patients Yueping Liu, Meiling Sun Clinics and Research in Hepatology and Gastroenterology.2023; 47(8): 102195. CrossRef
Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis Vincent Chin-Hung Chen, Shao-Lan Huang, Jing-Yu Huang, Tsai-Ching Hsu, Bor-Show Tzang, Roger S. McIntyre International Journal of Molecular Sciences.2023; 24(16): 12630. CrossRef
The Mediating Effect of Resilience on the Relationship Between Symptom Burden and Anxiety/Depression Among Chinese Patients with Primary Liver Cancer After Liver Resection Xue Zhang, Haoran Zhang, Zonghao Zhang, Hua Fan, Shuwen Li Patient Preference and Adherence.2023; Volume 17: 3033. CrossRef
Nonalcoholic fatty liver disease (NAFLD) affects about a third of the world’s adult population and is a major public health concern. NAFLD is defined by the presence of hepatic steatosis and the absence of other causes of liver disease. As NAFLD is closely associated with the presence of the metabolic syndrome, several experts have called for a change in nomenclature from NAFLD to metabolic-associated fatty liver disease (MAFLD) to better reflect the underlying pathophysiology of NAFLD as a metabolically driven disease and shift to a “positive” diagnostic criteria rather than one of exclusion. Recent studies have suggested that the global prevalence of MAFLD is higher than that of NAFLD, and patients with MAFLD have more metabolic comorbidities compared to those with NAFLD. Emerging data also suggest that all-cause and cardiovascular mortality may be higher in MAFLD compared with NAFLD. In this synopsis, we discuss differences in clinical features, prevalence and clinical outcomes between NAFLD and MAFLD. In addition, we highlight the advantages and disadvantages of a name change from NAFLD to MAFLD from the perspective of the scientific community, care providers and patients.
Citations
Citations to this article as recorded by
A nonlinear relationship between dietary inflammatory index and stroke among US adults with metabolic dysfunction-associated steatotic liver disease Renwei Guo, Juan Du European Journal of Gastroenterology & Hepatology.2025; 37(3): 272. CrossRef
Metabolic dysfunction-associated steatotic liver disease in adults Daniel Q. Huang, Vincent W. S. Wong, Mary E. Rinella, Jerome Boursier, Jeffrey V. Lazarus, Hannele Yki-Järvinen, Rohit Loomba Nature Reviews Disease Primers.2025;[Epub] CrossRef
Prospective Comparison of 2D-Shear Wave Elastography and Vibration-Controlled Transient Elastography in Assessing Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Qingxin Li, Yanhang Gao, Dongxuan Wang, Xiaoxue Zhu, Jing Jia, Lili Liu, Huining Tian, Lishuang Wang, Yingwen Zhang, Dezhi Zhang Academic Radiology.2025; 32(9): 5100. CrossRef
High sensitivity C-reactive protein may be a significant predictor of non-alcoholic fatty liver disease in non-obese adults: A four-year retrospective study Changxi Chen, Jiande Gong, Mengting Li, Shiyu Pan, Guitao Xia, Yuemei Xu, Hongliang Li, Qi Lin Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(12): 104224. CrossRef
Differential effects of sleep duration on cardiovascular risk in metabolic-associated fatty liver disease vs. without metabolic-associated fatty liver disease: evidence from National Health and Nutrition Examination Survey and Mendelian randomization Siyao Wang, Xinyi Liu, Jia He, Yihan Cui, Ai Jia European Journal of Gastroenterology & Hepatology.2025; 37(12): 1380. CrossRef
Narrative review of metabolic syndrome and its relationships with non-alcoholic fatty liver disease, gonadal dysfunction and obstructive sleep apnea Doha Reda Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
The Cardiometabolic Index Is an Independent Predictor of Metabolic-Dysfunction–Associated Fatty Liver Disease in a Korean Population Kyoung-Jin Park Journal of Laboratory Medicine and Quality Assurance.2025; 47(3): 98. CrossRef
Redefining fatty liver as metabolic dysfunction-associated steatotic liver disease: Implications of nomenclature changes for patients with diabetes Tulio L Correa, Nikki Duong World Journal of Hepatology.2025;[Epub] CrossRef
Based on Network Pharmacology and Gut Microbiota to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Metabolic‐Associated Fatty Liver Disease Linzi Li, Yuxian Zhang, Cong Zhou, Chengxiong Yang, Chunkai Rao, Daoping Zhang, Xu Ai, Xianqiang Shao, Jing Zhou, Yan Yang, Shanshan Lei Food Science & Nutrition.2025;[Epub] CrossRef
The Role of Metabolites in CSF on NAFLD Development: A Mendelian Randomisation Analysis Fang Liang, Tiegang Xiao, Bing Wang Endocrinology, Diabetes & Metabolism.2025;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease: Prevalence and progression in lean patients Gerard Stupecki, Emilia Kowalczyk, Agnieszka Ciba-Stemplewska, Magdalena Dolecka-Ślusarczyk, Iwona Gorczyca-Głowacka Polish Annals of Medicine.2025; : 1. CrossRef
Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease Ya Wang, Wanhan Song, Qianhua Yuan, Meiqing Mai, Mengliu Luo, Jiahua Fan, Peiwen Zhang, Honghui Guo Scandinavian Journal of Gastroenterology.2024; 59(4): 469. CrossRef
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim Metabolism.2024; 152: 155789. CrossRef
Association of composite dietary antioxidant index and muscle mass in individuals with metabolic associated fatty liver disease Jing Guo, Lin Shi, Yan Sun Clinics and Research in Hepatology and Gastroenterology.2024; 48(2): 102284. CrossRef
Integrative insights into cerebrometabolic disease: Understanding, management, and future prospects Gaili Yan, Xiangyu Zhang, Yang Liu, Pingping Guo, Yuanyuan Liu, Xin Li, V. Wee Yong, Mengzhou Xue Journal of Neurorestoratology.2024; 12(2): 100107. CrossRef
Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1 Chaoyuan Huang, Qiuhong Yong, Yihui Lu, Lu Wang, Yiyuan Zheng, Lina Zhao, Peiwu Li, Chong Peng, Wei Jia, Fengbin Liu Frontiers in Pharmacology.2024;[Epub] CrossRef
Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo Gut and Liver.2024; 18(2): 283. CrossRef
Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction Hee Jun Park, Sunyoung Lee, Jae Seung Lee Abdominal Radiology.2024; 49(9): 3036. CrossRef
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz-López, Araceli Pinto-León, Verónica Torres, Danette Guiñez, Nicolás Aliaga, Pablo Merino, Alexandra Sandoval, Natalia Covarrubias, Edith Pérez de Arce, Máximo Cattaneo, Alvaro Urzúa, Juan Pablo Robl International Journal of Molecular Sciences.2024; 25(8): 4387. CrossRef
Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities Muhammed Mubarak World Journal of Gastrointestinal Pathophysiology.2024;[Epub] CrossRef
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis Naqash Alam, Linying Jia, Ao Cheng, Honghao Ren, Yu Fu, Xinhua Ding, Ihtisham Ul Haq, Enqi Liu Frontiers in Pharmacology.2024;[Epub] CrossRef
Nonlinear relationship between the triglyceride–glucose index and alanine aminotransferase in children with short stature Qianqian Zhao, Youqian Li, Mei Zhang, Bo Ban Scientific Reports.2024;[Epub] CrossRef
Global Leadership Initiative on Malnutrition-defined malnutrition coexisting with visceral adiposity predicted worse long-term all-cause mortality among inpatients with decompensated cirrhosis Han Wang, Tianming Zhao, Gaoyue Guo, Wanting Yang, Xuqian Zhang, Fang Yang, Jie Yang, Yangyang Hui, Xiaoyu Wang, Binxin Cui, Xiaofei Fan, Huanli Jiao, Chao Sun Nutrition & Diabetes.2024;[Epub] CrossRef
Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: a cross-sectional study from NHANES Jia-Xin Dong, Li-Li Jiang, Yan-Peng Liu, Ai-Xi Zheng BMC Gastroenterology.2024;[Epub] CrossRef
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis Jingxuan Quek, Kai En Chan, Zhen Yu Wong, Caitlyn Tan, Bryan Tan, Wen Hui Lim, Darren Jun Hao Tan, Ansel Shao Pin Tang, Phoebe Tay, Jieling Xiao, Jie Ning Yong, Rebecca Wenling Zeng, Nicholas W S Chew, Benjamin Nah, Anand Kulkarni, Mohammad Shadab Siddiqu The Lancet Gastroenterology & Hepatology.2023; 8(1): 20. CrossRef
The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals Kai En Chan, Cheng Han Ng, Clarissa Elysia Fu, Jingxuan Quek, Gwyneth Kong, Yi Jie Goh, Rebecca Wenling Zeng, Michael Tseng, Manik Aggarwal, Benjamin Nah, Douglas Chee, Zhen Yu Wong, Sitong Zhang, Jiong-Wei Wang, Nicholas W.S. Chew, Yock Young Dan, Mohamm Clinical Gastroenterology and Hepatology.2023; 21(10): 2560. CrossRef
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis Jieling Xiao, Cheng Han Ng, Kai En Chan, Clarissa Fu, Phoebe Tay, Jie Ning Yong, Wen Hui Lim, Darren Jun Hao Tan, Nicholas Syn, Zhen Yu Wong, Michael Tseng, Nicholas Chew, Daniel Q. Huang, Yock Yong Dan, Vincent Wai-Sun Wong, Rohit Loomba, Mohammad S. Sid Journal of Clinical and Experimental Hepatology.2023; 13(4): 656. CrossRef
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, Jieling Xiao, Jie Ning Yong, Bryan Tan, Nicholas Syn, Jiong-Wei Wang, Nilofer Sayed, Eunice Tan, Nicholas WS Chew, Yock Young Dan, Mo Annals of Hepatology.2023; 28(1): 100762. CrossRef
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim Liver International.2023; 43(3): 608. CrossRef
Examining the interim proposal for name change to steatotic liver disease in the US population Cheng Han Ng, Kai En Chan, Mark Muthiah, Caitlyn Tan, Phoebe Tay, Wen Hui Lim, Darren Jun Hao Tan, Clarissa Elysia Fu, Jie Ning Yong, Zhen Yu Wong, Benjamin Koh, Nicholas WS Chew, Nicholas Syn, Daniel Q. Huang, Yock Young Dan, Mohammad S. Siddiqui, Arun J Hepatology.2023; 77(5): 1712. CrossRef
Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults” Hye Won Lee Clinical and Molecular Hepatology.2023; 29(1): 169. CrossRef
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, Pietro Lampertico, Maria Buti, Claude B. Sirlin, Mindie H. Nguyen, Rohit Loomba Nature Reviews Gastroenterology & Hepatology.2023; 20(12): 797. CrossRef
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease Peter Konyn, Aijaz Ahmed, Donghee Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S43. CrossRef
The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review George Chen, Bubu Banini, Albert Do, Joseph K. Lim Clinical and Molecular Hepatology.2023; 29(Suppl): S319. CrossRef
MAFLD: How is it different from NAFLD? Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George Clinical and Molecular Hepatology.2023; 29(Suppl): S17. CrossRef
Non-alcoholic fatty liver disease: Definition and subtypes Seul Ki Han, Soon Koo Baik, Moon Young Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S5. CrossRef
Global epidemiology of cirrhosis — aetiology, trends and predictions Daniel Q. Huang, Norah A. Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Rohit Loomba Nature Reviews Gastroenterology & Hepatology.2023; 20(6): 388. CrossRef
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski Biomedicines.2023; 11(4): 1097. CrossRef
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives Shang-Chin Huang, Chun-Jen Liu Clinical and Molecular Hepatology.2023; 29(2): 320. CrossRef
The growing burden of non-alcoholic fatty liver disease on mortality Ju-Yeon Cho, Won Sohn Clinical and Molecular Hepatology.2023; 29(2): 374. CrossRef
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review Young-Joo Jin Clinical and Molecular Hepatology.2023; 29(2): 414. CrossRef
Correlation of the pediatric metabolic index with NAFLD or MAFLD diagnosis, and serum adipokine levels in children Maria-Luisa Lazo-de-la-Vega-Monroy, Monica-del-Carmen Preciado-Puga, Yeniley Ruiz-Noa, Marcia Salum-Zertuche, Lorena-del-Rocio Ibarra-Reynoso Clinics and Research in Hepatology and Gastroenterology.2023; 47(6): 102137. CrossRef
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef
Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee Ultrasonography.2023; 42(3): 421. CrossRef
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik JHEP Reports.2023; 5(9): 100810. CrossRef
The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng, Qiang Zhu European Journal of Gastroenterology & Hepatology.2023; 35(8): 889. CrossRef
Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity Jung Gil Park Gut and Liver.2023; 17(4): 489. CrossRef
Saponins of Tomato Extract Improve Non-Alcoholic Fatty Liver Disease by Regulating Oxidative Stress and Lipid Homeostasis Ziming Yang, Li Zhang, Jinlei Liu, Albert S. C. Chan, Dianpeng Li Antioxidants.2023; 12(10): 1848. CrossRef
Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China Mingxing Chang, Zhihao Shao, Wei Wei, Peipu Shen, Guifang Shen Frontiers in Endocrinology.2023;[Epub] CrossRef
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk Keungmo Yang, Myeongjun Song Nutrients.2023; 15(18): 3970. CrossRef
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population Pei Zeng, Xiangsheng Cai, Xiaozhou Yu, Linjing Gong Scientific Reports.2023;[Epub] CrossRef
A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population Chih-Yi Ho, Jia-In Lee, Shu-Pin Huang, Szu-Chia Chen, Jiun-Hung Geng Nutrients.2023; 16(1): 77. CrossRef
Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis Nan Yao, Yixue Yang, Xiaotong Li, Yuxiang Wang, Ruirui Guo, Xuhan Wang, Jing Li, Zechun Xie, Bo Li, Weiwei Cui Frontiers in Nutrition.2022;[Epub] CrossRef
The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach Aurelio Seidita, Maurizio Soresi, Lydia Giannitrapani, Vita Di Stefano, Roberto Citarrella, Luigi Mirarchi, Antonella Cusimano, Giuseppa Augello, Antonio Carroccio, Juan Lucio Iovanna, Melchiorre Cervello Frontiers in Nutrition.2022;[Epub] CrossRef
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH Darren Jun Hao Tan, Veronica Wendy Setiawan, Cheng Han Ng, Wen Hui Lim, Mark D. Muthiah, Eunice X. Tan, Yock Young Dan, Lewis R. Roberts, Rohit Loomba, Daniel Q. Huang Hepatology.2022; : n/a. CrossRef
The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population Ji Yeon Seo, Eun Ju Cho, Min Joo Kim, Min‐Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Ji Won Yoon, Goh Eun Chung Journal of Cachexia, Sarcopenia and Muscle.2022; 13(6): 2953. CrossRef
Association between flavonoid and subclasses intake and metabolic associated fatty liver disease in U.S. adults: Results from National Health and Nutrition Examination Survey 2017–2018 Junlu Tong, Yingjuan Zeng, Jianhui Xie, Kecen Xiao, Man Li, Li Cong Frontiers in Nutrition.2022;[Epub] CrossRef
Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes Xiaodan Zhang, Yimei Chen, Huiyu Ye, Zirui Luo, Jiahong Li, Zhishan Chen, Enting Zhang, Wangen Li Endocrine.2022; 80(2): 366. CrossRef
First
Prev
